Document:

<PAGE>

                                                                 Exhibit 10.8

             ------------------------------------------------------

                               FURNITURE.COM, INC.
             Series D Convertible Preferred Stock Purchase Agreement

                          Dated as of December 30, 1999

             ------------------------------------------------------

<PAGE>

                               FURNITURE.COM, INC.

             SERIES D CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT

                          Dated as of December 30, 1999

                                TABLE OF CONTENTS
<TABLE>
<CAPTION>

<S>                                                                                                               <C>
ARTICLE I

         PURCHASE, SALE AND TERMS OF SHARES........................................................................1
                  1.01.    THE PURCHASED SHARES....................................................................1
                  1.02.    PURCHASE PRICE AND CLOSING..............................................................1
                  1.03.    USE OF PROCEEDS.........................................................................2
                  1.04.    REPRESENTATIONS AND WARRANTIES BY THE PURCHASERS........................................2
                  1.05.    PERMITTED TRANSFERS.....................................................................3

ARTICLE II

         CONDITIONS TO PURCHASERS' OBLIGATION......................................................................4
                  2.01.    REPRESENTATIONS AND WARRANTIES..........................................................4
                  2.02.    DOCUMENTATION AT CLOSING................................................................4
                  2.03.    CONSENTS, WAIVERS, ETC..................................................................6
                  2.04.    DUE DILIGENCE...........................................................................6

ARTICLE III

         REPRESENTATIONS AND WARRANTIES............................................................................6
                  3.01.    ORGANIZATION AND STANDING OF THE COMPANY AND EACH OF ITS SUBSIDIARIES...................6
                  3.02.    CORPORATE ACTION........................................................................6
                  3.03.    GOVERNMENTAL APPROVALS..................................................................6
                  3.04.    LITIGATION..............................................................................7
                  3.05.    CERTAIN AGREEMENTS OF OFFICERS AND KEY EMPLOYEES........................................7
                  3.06.    COMPLIANCE WITH OTHER INSTRUMENTS.......................................................8
                  3.07.    [RESERVED]..............................................................................8
                  3.08.    TAXES...................................................................................8
                  3.09.    ERISA...................................................................................8
                  3.10.    TRANSACTIONS WITH AFFILIATES............................................................8
                  3.11.    ASSUMPTIONS OR GUARANTEES OF INDEBTEDNESS OF OTHER PERSONS..............................9
                  3.12.    INVESTMENTS IN OTHER PERSONS............................................................9
                  3.13.    SECURITIES ACT..........................................................................9
                  3.14.    DISCLOSURE..............................................................................9
                  3.15.    BROKERS OR FINDERS......................................................................10
                  3.16.    CAPITALIZATION; STATUS OF CAPITAL STOCK.................................................10
                  3.16A.   CAPITAL STOCK OF SUBSIDIARIES...........................................................10
                  3.17.    REGISTRATION RIGHTS.....................................................................11
</TABLE>

                                       i
<PAGE>

<TABLE>
<CAPTION>

<S>                                                                                                               <C>

                  3.18.    INSURANCE...............................................................................11
                  3.19.    BOOKS AND RECORDS.......................................................................11
                  3.20.    TITLE TO ASSETS, PATENTS................................................................11
                  3.21.    REAL PROPERTY HOLDING CORPORATION STATUS................................................12
                  3.22.    LABOR RELATIONS.........................................................................12
                  3.23.    OTHER AGREEMENTS........................................................................13
                  3.24.    ENVIRONMENTAL PROTECTION................................................................15
                  3.25.    COMPLIANCE WITH LAW; PERMITS............................................................15
                  3.26.    FINANCIAL STATEMENTS....................................................................16
                  3.27.    YEAR 2000 COMPLIANCE....................................................................16

ARTICLE IV

         COVENANTS OF THE COMPANY

                  4.01.    AFFIRMATIVE COVENANTS OF THE COMPANY OTHER THAN REPORTING REQUIREMENTS..................16
                  4.02.    NEGATIVE COVENANTS OF THE COMPANY.......................................................19
                  4.03.    REPORTING REQUIREMENTS..................................................................21

ARTICLE V

         RIGHT OF FIRST REFUSAL....................................................................................23
                  5.01.    RIGHT OF FIRST REFUSAL..................................................................23
                  5.02.    NOTICE OF ACCEPTANCE....................................................................23
                  5.03.    CONDITIONS TO ACCEPTANCES AND PURCHASE..................................................24
                  5.04.    FURTHER SALE............................................................................24
                  5.05.    TERMINATION OF RIGHT OF FIRST REFUSAL...................................................24
                  5.06.    EXCEPTION...............................................................................24
                  5.07.    FIRST QUALIFIED PUBLIC OFFERING.........................................................25

ARTICLE VI

         DEFINITIONS AND ACCOUNTING TERMS..........................................................................28
                  6.01.    CERTAIN DEFINED TERMS...................................................................28
                  6.02.    ACCOUNTING TERMS........................................................................31

ARTICLE VII

         MISCELLANEOUS.............................................................................................31

                  7.01.    NO WAIVER; CUMULATIVE REMEDIES..........................................................31
                  7.02.    AMENDMENTS, WAIVERS AND CONSENTS........................................................31
                  7.03.    ADDRESSES FOR NOTICES...................................................................31
                  7.04.    COSTS, EXPENSES AND TAXES...............................................................32
                  7.05.    BINDING EFFECT; ASSIGNMENT..............................................................32
                  7.06.    SURVIVAL................................................................................33
                  7.07.    PRIOR AGREEMENTS........................................................................33
                  7.08.    SEVERABILITY............................................................................33
                  7.09.    GOVERNING LAW...........................................................................33
</TABLE>

                                       ii
<PAGE>

<TABLE>

<S>                                                                                                               <C>

                  7.10.    HEADINGS................................................................................33
                  7.11.    COUNTERPARTS............................................................................33
                  7.12.    FURTHER ASSURANCES......................................................................33
                  7.13.    INDEMNIFICATION.........................................................................33
                  7.14.    AGGREGATION OF STOCK....................................................................34
                  7.15.    CONFIDENTIALITY.........................................................................34
</TABLE>

                                       iii
<PAGE>

EXHIBITS

1.01              List of Purchasers
1.01A             Purchaser Signature Page
1.01B             Restated Certificate of Incorporation
2.02B             Form of Opinion of Counsel
2.02F             Stockholders' Agreement
2.02J             Registration Rights Agreement
3.04              Litigation
3.05              Certain Agreements of Officers and Key employees
3.06              Compliance with Other Instruments
3.08              Taxes
3.09              ERISA
3.10              Transactions with Affiliates
3.11              Assumptions or Guaranties of Indebtedness of Other Persons
3.12A             Loans or Advances
3.12B             Subsidiaries
3.14              Material Contracts
3.16              Capitalization
3.17              Registration Rights
3.18              Insurance
3.20              Title to Assets, Patents
3.22              Labor Relations
3.23(a)           Other Agreements - Distributors/Vendors
3.23(b)           Other Agreements - Sales Contracts with Rebate/Right of
                  Set-Off
3.23(c)           Other Agreements - Contracts with Labor Unions
3.23(d)           Other Agreements - Contracts Permitting Renegotiation of Price
3.23(e)           Other Agreements - Purchase of Fixed Assets
3.23(f)           Other Agreements - Employment
3.23(g)           Employee Benefit Plans
3.23(h)           Schedule of Loans with Security Interest
3.23(i)           Guaranty of Obligation for Borrowed Money
3.23(j)           Voting, Stockholder, Pledge or Buy Sell Agreements
3.23(k)(A)        Agreements to Lease Real Property as Lessee or Lessor
3.23(k)(B)        Other Agreements - Equipment Leases
3.23(l)           Agreements to Acquire or Retire Equity Securities
3.23(m)           Intangible Property
3.23(n)           Consulting and Professional Agreements
3.23(o)           Required to be Filed with the SEC with Registration Statement
3.23(p)           Agreements to Exercise Buyout Provision of any Lease
3.23A             Present Expectations or Intentions of Non-Performance
3.24              Environmental Protection
3.25              Compliance with Law; Permits
4.02(a)           Indebtedness
4.02(h)           Dealings with Affiliates and Others

                                       iv
<PAGE>

                                                        As of December 30, 1999

TO:      The Persons listed on EXHIBIT 1.01 hereto

               Re:         PURCHASE OF SERIES D CONVERTIBLE PREFERRED STOCK

Ladies and Gentlemen:

               Furniture.com, Inc. (the "Company"), a Delaware corporation,
agrees with each of you as follows:

                                    ARTICLE I

                       PURCHASE, SALE AND TERMS OF SHARES

         1.01.....THE PURCHASED SHARES. The Company has authorized the issuance
and sale of up to 3,200,000 shares of its authorized but unissued shares of
Series D Convertible Preferred Stock, $.01 par value (the "Series D Preferred"),
at a purchase price of $9.40 per share to the persons (collectively, the
"Purchasers" and, individually, a "Purchaser") and in the respective amounts set
forth in EXHIBIT 1.01 hereto. Each Purchaser shall become a party to this
Agreement by the execution and delivery of signature pages in the form of
EXHIBIT 1.01A hereto (the "Purchaser Signature Page") and to the Stockholders'
Agreement and Registration Rights Agreement (each as defined below). The
designation, rights, preferences and other terms and conditions relating to the
Series D Preferred shall be as set forth in the Fourth Amended and Restated
Certificate of Incorporation of the Company (the "Restated Certificate of
Incorporation"), attached hereto as EXHIBIT 1.01B.

          The Series D Preferred as now held or as hereafter acquired is
sometimes referred to herein as the "Purchased Shares" and the Purchased Shares
and the Converted Shares (as defined in Article VI hereof) are sometimes
collectively referred to herein as the "Shares."

         1.02     PURCHASE PRICE AND CLOSING.

                 (a) Subject to and in reliance upon the representations,
warranties, covenants, terms and conditions of this Agreement, the Company
agrees to issue and sell to the Purchasers, and the Purchasers, severally but
not jointly, agree to purchase that number of Purchased Shares set forth
opposite their respective names in EXHIBIT 1.01. The aggregate purchase price of
the Purchased Shares being purchased by each Purchaser is set forth opposite
such Purchaser's name in EXHIBIT 1.01. The purchase and sale shall take place at
a closing (the "Closing") to be held at the offices of Hale and Dorr LLP, 60
State Street, Boston, Massachusetts on December 30, 1999, at 10:00 A.M., or at
such other location, on such other date and at such time as the Company and the
Purchasers may mutually agree upon. At the Closing, the Company will issue and
deliver certificates evidencing the Purchased Shares to be sold at such Closing
to each of the Purchasers against payment to the Company of the full purchase
price therefor by (i) wire transfer, (ii) certified bank or cashier's check
payable to the order of the Company, or (iii) any combination of (i) and (ii)
above.

                                       1
<PAGE>

                  (b) The Company may sell, at any time prior to January 5,
2000, in one or more closings (each, a "Subsequent Closing"), additional
Purchased Shares (but together with the Purchased Shares sold at the Closing not
more than an aggregate of 3,200,000 Purchased Shares) at a purchase price of
$9.40 per share, to such purchasers (each, an "Additional Purchaser") as may be
approved by the Chief Executive Officer of the Company. At each Subsequent
Closing, (i) the Company and each Additional Purchaser shall execute and deliver
a counterpart Purchaser Signature Page hereto, whereupon such Additional
Purchaser shall become a "Purchaser" hereunder and the Purchased Shares
purchased by such Additional Purchaser shall be deemed "Purchased Shares" for
purposes of this Agreement, and (ii) the Company shall cause EXHIBIT 1.01 hereto
to be amended to reflect the purchases made by the Additional Purchasers at each
Subsequent Closing by such Additional Purchaser, registered in the name of such
Additional Purchaser, against payment to the Company in the manner specified
above. The Company shall deliver to each Purchaser, within 15 days after any
Subsequent Closing, written notice of such Subsequent Closing (which notice
shall specify the names of each Additional Purchaser and the number of shares of
Series D Preferred issued to each).

         1.03     USE OF PROCEEDS. The Company shall use the proceeds from the
sale of the Purchased Shares for working capital and general corporate purposes.

         1.04     REPRESENTATIONS AND WARRANTIES BY THE PURCHASERS. Each of the
Purchasers represents and warrants severally, but not jointly, that (a) it is
acquiring the Shares, for its own account and that the Shares are being and will
be acquired by it for the purpose of investment and not with a view to, or in
connection with, subdivision, distribution or resale thereof in violation of any
State or Federal securities laws; (b) the execution of this Agreement and the
consummation of the transactions contemplated hereby have been duly authorized
by all necessary action (if any) on the part of the Purchaser, and this
Agreement has been duly executed and delivered, and constitutes a valid, legal,
binding and enforceable agreement of the Purchaser; (c) it is an "accredited
investor" within the meaning of Rule 501 of Regulation D promulgated under the
Securities Act (as defined in Article VI hereof); (d) it has taken no action
which would give rise to any claim by any other person for any other person for
any brokerage commissions, finders' fees or the like relating to this Agreement
or the transactions contemplated hereby; (e) the individual executing this
Agreement has appropriate authority to act on behalf of such Purchaser; (f) it
was not specifically formed to acquire the Shares subscribed for hereby; (g) it
understands that there is no market for the Shares and that there is no
assurance that such a market will develop and the Purchaser has no present need
for liquidity with respect to its investment; (h) it is able to bear the
economic risk of its investment for an indefinite period of time and can afford
a complete loss of its investment; (i) it has sufficient knowledge and
experience investing in companies similar to the Company in terms of the
Company's early stage of development and it understands that an investment in
the Company involves a very high degree of risk and it has taken full cognizance
of and understands such risks; (j) it has such knowledge and experience in
financial and business matters that it is capable of evaluating the merits and
risks of an investment in the Company, has evaluated such risks and has
determined that the Shares are a suitable investment for it; (k) it understands
that no Federal or State agency has made any finding or determination as to the
fairness for investment in, or any recommendation or endorsement of, the Shares;
(l) it has had an opportunity to discuss the Company's business, management and
financial affairs with the Company's management and has received from the
Company all such information concerning the Company as it has

                                       2
<PAGE>

requested; (m) it has consulted its own attorney, accountant or investment
advisor with respect to the investment contemplated hereby and its suitability
for the Purchaser; (n) its overall commitment to investments which are not
readily marketable is not disproportionate to the net worth of the Purchaser,
and the Purchaser's investment in the Shares will not cause such overall
commitment to become excessive; and (o) it received an offer concerning the
Shares and first learned of this investment in the state or other jurisdiction
listed in the address of such Purchaser on the attached EXHIBIT 1.01 hereto. The
Purchasers' representations under this Section 1.04, however, shall not limit or
modify the representations and warranties of the Company in Article III of this
Agreement or the right of the Purchasers to rely thereon. The acquisition by
each Purchaser of the Shares acquired by it shall constitute a confirmation as
of the date of such acquisition of the representations and warranties made
herein by each such Purchaser.

             Each Purchaser understands that the Shares have not been registered
under the Securities Act, or the securities laws of any State by reason of their
issuance in a transaction exempt from the registration requirements of the
Securities Act pursuant to Section 4(2) thereof or Rule 506 promulgated under
the Securities Act, and applicable State securities laws.

                   Each of the Purchasers further represents that it understands
and agrees that Company has no current obligation to register the Shares and
that, until registered under the Securities Act or transferred pursuant to the
provisions of Rule 144 as promulgated by the Securities and Exchange Commission,
all certificates evidencing any of the Shares, whether upon initial issuance or
upon any transfer thereof, shall bear a legend, prominently stamped or printed
thereon, reading substantially as follows:

                     "The securities represented by this certificate have not
         been registered under the Securities Act of 1933 or applicable State
         securities laws. These securities have been acquired for investment and
         not with a view to distribution or resale, and may not be sold,
         mortgaged, pledged, hypothecated or otherwise transferred without an
         effective registration statement for such securities under the
         Securities Act of 1933 and applicable State securities laws, unless the
         holder shall have obtained an opinion of counsel satisfactory to the
         issuer of these securities as to the availability of an exemption from
         the registration provisions of the Securities Act of 1933 and
         applicable State securities laws."

              The foregoing representations, warranties, agreements,
undertakings and acknowledgments are made by each Purchaser with the intent that
they be relied upon in determining its suitability as a purchaser of the Shares.

         1.05     PERMITTED TRANSFERS. The Company agrees that it will permit
(X) a transfer of Purchased Shares or Converted Shares (i) to one or more of its
partners or members in any Purchaser that is a partnership or limited liability
company or to a retired or withdrawn partner or member who retires or withdraws
after the date hereof in full or partial distribution of his interest in such
partnership or limited liability company, (ii) to any immediate family member
(which shall be deemed to include a spouse, sibling, lineal descendant,
ancestor, mother-in-law, father-in-law, brother-in-law and sister-in-law) of an
individual Purchaser by gift or bequest or through inheritance, or to a trust or
family limited partnership (or other similar entity) created for the benefit of
one or more of the foregoing, (iii) to any shareholder of any Purchaser that is
a corporation or (iv) to any person or entity acquiring at least 250,000 shares
of Series D Preferred

                                       3
<PAGE>

(such number being subject to adjustment for any stock dividend, stock split,
subdivision, combination or other recapitalization); PROVIDED, HOWEVER, that the
transferor provides written notice of such transfer to the Company stating the
transferee's name and address and specifying the number and type of securities
to be transferred; and PROVIDED, FURTHER, that the Company receives a written
instrument pursuant to which the transferee agrees to be subject to the terms
hereof to the same extent as if it were an original Purchaser hereunder and (Y)
a sale or other transfer of any of the Purchased Shares or Converted Shares upon
obtaining assurance satisfactory to the Company that such transaction is exempt
from the registration requirements of, or is covered by an effective
registration statement under, the Act and applicable state securities or
"blue-sky" laws, including, without limitation, receipt of an unqualified
opinion to such effect of counsel reasonably satisfactory to the Company.
Notwithstanding anything herein to the contrary, in no event may any Purchaser,
together with its affiliates and transferees, transfer any Purchased Shares or
Converted Shares to more than 10 persons in the aggregate.

                                   ARTICLE II

                      CONDITIONS TO PURCHASERS' OBLIGATION

             The obligation of each Purchaser to purchase and pay for the Shares
to be purchased by it at the Closing is subject to the following conditions, all
of which shall be deemed satisfied or waived in the event that the transactions
contemplated herein to be effected at the Closing are consummated:

         2.01     REPRESENTATIONS AND WARRANTIES. Each of the representations
and warranties of the Company and its Subsidiaries (as defined in Article VI
hereof) set forth in Article III hereof shall be true and correct on the date of
the Closing.

         2.02     DOCUMENTATION AT CLOSING. The Purchasers shall have received
prior to or at the Closing all of the following documents or instruments, or
evidence of completion thereof, each in form and substance satisfactory to the
Purchasers and their counsel, or each of the following events shall have
occurred prior to or at the Closing.

                  (a) A copy of the Restated Certificate of Incorporation of the
Company and Articles of Organization of each of its Subsidiaries, in each case
certified by the Secretary of State of the jurisdiction of their respective
organization, a copy of the resolutions of the Board of Directors and, if
required, the stockholders of the Company evidencing the adoption of the
Restated Certificate of Incorporation, the approval of this Agreement, the
issuance of the Shares and the other matters contemplated hereby, a copy of the
Bylaws of the Company and of each of the Company's Subsidiaries, all of which
have been certified by the Secretary of the Company to be true, complete and
correct in every particular, and certified copies of all documents evidencing
other necessary corporate or other action and governmental approvals, if any,
with respect to this Agreement and the Shares.

                  (b) An opinion of Hale and Dorr LLP, counsel to the Company,
in the form of EXHIBIT 2.02B attached hereto.

                  (c) A certificate of the Secretary of the Company which shall
certify the names of the officers of the Company authorized to sign this
Agreement, the certificates for the

                                       4
<PAGE>

Purchased Shares, and the other documents, instruments or certificates to be
delivered pursuant to this Agreement by the Company or any of its officers,
together with the true signatures of such officers.

                  (d) A certificate of the President of the Company stating that
the representations and warranties of the Company and its Subsidiaries contained
in Article III hereof and otherwise made by the Company in writing in connection
with the transactions contemplated hereby are true and correct and that all
conditions required to be performed by the Company and its Subsidiaries prior to
or at the Closing have been performed or waived as of the Closing.

                  (e) The Restated Certificate of Incorporation of the Company
shall provide for the designation of the rights and preferences of the Class A
Common Stock, the Class B Common Stock, the Series A Preferred, the Series B
Preferred, the Series C Preferred and the Series D Preferred in the form set
forth in EXHIBIT 1.01A, attached hereto.

                  (f) A Third Amended and Restated Stockholders' Agreement in
the form set forth in EXHIBIT 2.02F (the "Stockholders' Agreement") shall have
been executed by such of the parties named therein as requested by the
Purchasers.

                  (g) Certificates of Good Standing for the Company and each of
its Subsidiaries (i) from the jurisdiction of their respective organization and
(ii) from any other jurisdiction in which the character of the property owned or
leased, or the nature of the activities conducted, by the Company or any of its
Subsidiaries makes such licensing or qualification necessary, shall have been
provided to the Purchasers and their counsel.

                  (h) Payment for the costs, expenses, taxes and filing fees
identified in Section 7.04.

                  (i) The Bylaws of the Company shall provide for a Board of
Directors consisting of eight (8) members, who shall be designated in accordance
with the Stockholders' Agreement.

                  (j) The Company and the Purchasers shall have entered into a
Third Amended and Restated Registration Rights Agreement (the "Registration
Rights Agreement") in the form set forth in EXHIBIT 2.02J.

                   (k) The Company shall have reserved a total of not more than
4,500,000 shares of Class B Common Stock as Reserved Management Shares (as
defined in Article VI), which such number shall include the Reserved Management
Shares that have been previously been reserved.

                  (l) The Company shall have reserved 3,200,000 shares of Class
B Common Stock as Converted Shares.

         2.03     CONSENTS, WAIVERS, ETC. Prior to the Closing the Company shall
have obtained all consents or waivers, if any, necessary to execute and deliver
this Agreement, issue the Shares and to carry out the transactions contemplated
hereby, and all such consents and waivers shall be

                                       5
<PAGE>

in full force and effect at the Closing. All corporate and other action and
governmental filings necessary to effectuate the terms of this Agreement, the
Shares and other agreements and instruments executed and delivered by the
Company in connection herewith shall have been made or taken, except for any
post-sale filing that may be required under Federal or State securities laws.

         2.04     DUE DILIGENCE.  The Purchasers shall have completed their due
diligence investigation of the Company and its Subsidiaries to their
satisfaction.

                                   ARTICLE III

                         REPRESENTATIONS AND WARRANTIES

          The Company hereby represents and warrants as follows as of the date
of the Closing (it being understood and agreed that the representations and
warranties herein relate to the business of the Company and each of its
Subsidiaries taken as a whole):

         3.01     ORGANIZATION AND STANDING OF THE COMPANY AND EACH OF ITS
SUBSIDIARIES. The Company and each of its Subsidiaries is a duly organized and
validly existing corporation in good standing under the laws of the State of its
incorporation and has all requisite corporate power and authority for the
ownership and operation of its properties and for the carrying on of its
business as now conducted or as proposed to be conducted. The Company and each
of its Subsidiaries is duly licensed or qualified and in good standing as a
foreign corporation authorized to do business in all jurisdictions wherein the
character of the property owned or leased, or the nature of the activities
conducted by it, makes such licensing or qualification necessary, except where
the failure to be so licensed or qualified would not have a Material Adverse
Effect (as defined in Article VI).

         3.02     CORPORATE ACTION. The Company has all necessary corporate
power and has taken all corporate action required to make all the provisions of
this Agreement and any other agreements (including the Stockholders' Agreement
and Registration Rights Agreement) and instruments executed in connection
herewith and therewith be the valid and binding obligations of the Company,
enforceable in accordance with their respective terms. The issuance of the
Purchased Shares, and the issuance of the Converted Shares upon conversion of
the Purchased Shares will not be subject to preemptive rights or other
preferential rights in any present or future shareholders of the Company and
will not conflict with any provision of any agreement or instrument to which the
Company is a party or by which it or its property is bound.

         3.03     GOVERNMENTAL APPROVALS. Except for the filing of any notice
subsequent to the Closing that may be required under applicable State and/or
Federal securities laws (which, if required, shall be filed on a timely basis),
no authorization, consent, approval, license, exemption of or filing or
registration with any court or governmental department, commission, board,
bureau, agency or instrumentality, domestic or foreign, is or will be necessary
for the execution and delivery by the Company of this Agreement, for the offer,
issue, sale and delivery of the Shares, or for the performance by the Company of
its obligations under this Agreement.

         3.04     LITIGATION. Except as set forth on EXHIBIT 3.04 hereto, there
is no litigation or governmental proceeding or investigation pending or, to the
knowledge of the Company,

                                       6
<PAGE>

threatened against the Company or any of its Subsidiaries affecting any of its
respective properties or assets, or, to the best knowledge of the Company,
against any Key Employee (as defined in Article VI hereof) affecting such
person's performance of duties for the Company, his share ownership in the
Company or any of its Subsidiaries or otherwise relating to the business of the
Company or any of its Subsidiaries, nor, to the best knowledge of the Company,
has there occurred any event nor does there exist any condition on the basis of
which any such litigation, proceeding or investigation might properly be
instituted, which if adversely determined would result in a Material Adverse
Effect. Neither the Company nor any of its Subsidiaries, nor, to the knowledge
of the Company, Key Employee or holder of the capital stock of the Company
(other than any Purchaser) or any of its Subsidiaries is in default with respect
to any order, writ, injunction, decree, ruling or decision of any court,
commission, board or other government agency that might result in any case, or
in the aggregate, in any Material Adverse Effect. Except as set forth on EXHIBIT
3.04 hereto, there are no actions or proceedings pending or, to the knowledge of
the Company, threatened (or any basis therefor known to the Company) which might
result, either in any case or in the aggregate, in any material adverse effect
on the business, operations, affairs or condition of the Company or any of its
Subsidiaries or in their properties or assets taken as a whole, or which might
call into question the validity of this Agreement, any of the Shares, or any
action taken or to be taken pursuant hereto or thereto. The foregoing sentences
include, without limiting their generality, actions pending or threatened (or
any basis therefor known to the Company) involving the prior employment of any
of the officers or employees of the Company or any of its Subsidiaries or their
use in connection with the business of the Company or any of its Subsidiaries of
any information or techniques allegedly proprietary to any of their former
employers.

         3.05     CERTAIN AGREEMENTS OF OFFICERS AND KEY EMPLOYEES.

                  (a) Except as set forth on EXHIBIT 3.05, to the Company's
knowledge, except in instances which will not result in a Material Adverse
Effect, no officer or Key Employee of the Company or any of its Subsidiaries is,
or is now expected to be, in violation of any term of any employment contract,
patent disclosure agreement, proprietary information agreement, noncompetition
agreement, or any other contract or agreement or any restrictive covenant
relating to the right of any such officer or Key Employee to be employed by the
Company or any of its Subsidiaries because of the nature of the business
conducted or to be conducted by the Company or any of its Subsidiaries or
relating to the use of trade secrets or proprietary information of others, and
to the Company's knowledge and belief, the continued employment of the officers
and Key Employees of the Company or any of its Subsidiaries does not subject the
Company, any of its Subsidiaries or any Purchaser to any liability arising out
of the foregoing contracts or agreements.

                  (b) Except as set forth on EXHIBIT 3.05, to the knowledge of
the Company, no officer of the Company or any of its Subsidiaries, nor any Key
Employee of the Company or any of its Subsidiaries whose termination, either
individually or in the aggregate, would have a Material Adverse Effect on the
Company, has expressed any present intention of terminating his employment in
such capacity.

         3.06     COMPLIANCE WITH OTHER INSTRUMENTS. Except as set forth on
EXHIBIT 3.06, the Company and each of its Subsidiaries is in compliance in all
respects with the terms and

                                       7
<PAGE>

provisions of this Agreement and of its Restated Certificate of Incorporation
(or Articles of Organization, as the case may be) and Bylaws, and in all
material respects with the terms and provisions of all material mortgages,
indentures, leases, agreements and other instruments, if any, by which it is
bound or to which it or any of its respective properties or assets are subject,
except where noncompliance would not result in a Material Adverse Effect. Except
as set forth on EXHIBIT 3.06, the Company and each of its Subsidiaries is in
compliance in all material respects with all judgments, decrees, governmental
orders, statutes, rules or regulations by which it is bound or to which any of
its properties or assets are subject, except where such noncompliance would not
result in a Material Adverse Effect. The Company and each of its Subsidiaries
possesses all authorizations, approvals, orders, licenses, registrations,
certificates and permits of and from all governmental regulatory officials and
bodies necessary to conduct their respective businesses, except where such
failure would not have a Material Adverse Effect. Neither the execution,
issuance and delivery of this Agreement, nor the consummation of any transaction
contemplated hereby or thereby, has constituted or resulted in or will
constitute or result in a default or violation of any material term or provision
of any of the foregoing documents, instruments, judgments, agreements, decrees,
orders, statutes, rules and regulations, except where such default or violation
would not, in the best knowledge of the Company, result in a Material Adverse
Effect.

         3.07     [Reserved]

         3.08     TAXES. Except as set forth on EXHIBIT 3.08, the Company and
each of its Subsidiaries have prepared correctly in all material respects and
timely filed all Federal, State, foreign and other tax returns required under
the laws of any applicable jurisdiction to be filed by them, have paid or made
provision for the payment of all taxes, including sales taxes, due from the
Company and each of its Subsidiaries, respectively, and all additional
assessments (whether or not shown on such returns) except where such nonpayment
or lack or provision would not result in a Material Adverse Effect. Except as
set forth on EXHIBIT 3.08, none of the Federal income tax returns of the Company
or any of its Subsidiaries have been audited by the Internal Revenue Service.
The Company does not know of any additional assessments or adjustments pending
or threatened against the Company or any of its Subsidiaries, as the case may
be, for any period, nor of any basis for any such assessment or adjustment.

         3.09     ERISA. Except as set forth in EXHIBIT 3.09, neither the
Company nor any of its Subsidiaries makes or has any present intention to make
any contributions to or has incurred any liability with respect to any employee
pension benefit plans for its employees which are subject to ERISA.

         3.10     TRANSACTIONS WITH AFFILIATES. Except as contemplated hereby
and except as set forth on EXHIBIT 3.10, there are no loans, leases, royalty
agreements or other continuing transactions between any officer, employee or
director of the Company or any of its Subsidiaries or any Person (as defined in
Article VI hereof) owning capital stock of the Company or any of its
Subsidiaries or any member of the immediate family of such officer, employee,
director or stockholder or any corporation or other entity controlled by such
officer, employee, director or stockholder or a member of the immediate family
of such officer, employee, director or stockholder; PROVIDED that the term
"continuing transactions" shall not be deemed to include

                                       8
<PAGE>

ongoing employment arrangements between the Company and its employees or
officers that are consistent with, and entered into in, the ordinary course of
business.

         3.11     ASSUMPTIONS OR GUARANTEES OF INDEBTEDNESS OF OTHER PERSONS.
Except as contemplated hereby and except as set forth in EXHIBIT 3.11, neither
the Company nor any of its Subsidiaries have assumed, guaranteed, endorsed or
otherwise become directly or contingently liable on (including, without
limitation, liability by way of agreement, contingent or otherwise, to purchase,
to provide funds for payment, to supply funds to or otherwise invest in the
debtor or otherwise to assure the creditor against loss), which remains
currently outstanding, any Indebtedness (as defined in Article VI hereof) of any
other Person, including any of its Subsidiaries.

         3.12     INVESTMENTS IN OTHER PERSONS. Except as contemplated hereby
and except as set forth in EXHIBIT 3.12A, neither the Company nor any of its
Subsidiaries have made any loan or advance to any Person which is outstanding on
the date of this Agreement, nor are the Company or any of its Subsidiaries
committed or obligated to make any such loan or advance, nor does the Company or
any of its Subsidiaries own any capital shares, assets comprising the business
of, obligations of, or any interest in, any Person except as disclosed in this
Agreement. Except as set forth in EXHIBIT 3.12B, the Company has no
Subsidiaries.

         3.13     SECURITIES ACT. To the best knowledge of the Company, the
Company has complied and will comply with all applicable Federal and State
securities laws in connection with the offer, issuance and sale of the Shares.
Neither the Company nor anyone acting on its behalf has or will sell, offer to
sell or solicit offers to buy the Shares or similar securities to, or solicit
offers with respect thereto from, or enter into any preliminary conversations or
negotiations relating thereto with, any Person, so as to bring the issuance and
sale of the Shares under the registration provisions of the Securities Act and
applicable State securities laws.

         3.14     DISCLOSURE. This Agreement, including all Schedules and
Exhibits hereto, does not contain any untrue statement of a material fact nor
does it omit to state a material fact necessary in order to make the statements
contained herein or therein not misleading in light of the circumstances under
which they are or were made. There is no fact within the knowledge of the
Company which has not been disclosed herein or in writing by it to the
Purchasers and which would have a Material Adverse Effect. Neither the Company
nor any of its Subsidiaries has, and the Company has no reasonable grounds to
know of, any liability, contingent or otherwise, other than outstanding payables
to furniture vendors, in an amount exceeding $1,000,000, other than those
liabilities described on EXHIBIT 3.10 or EXHIBIT 3.14 or the contracts described
in EXHIBIT 3.23.

         3.15     BROKERS OR FINDERS. No Person has or will have, as a result of
the transactions contemplated by this Agreement, any right, interest or valid
claim against or upon the Company or any of its Subsidiaries for any commission,
fee or other compensation as a finder or broker because of any act or omission
by the Company, any of its Subsidiaries or any of their respective agents.

         3.16     CAPITALIZATION; STATUS OF CAPITAL STOCK. The Company has a
total authorized capitalization consisting of (i) 33,000,000 shares of Class B
Common Stock, $.01 par value, of

                                       9
<PAGE>

which 6,208,070 shares are issued and outstanding on the date hereof, (ii)
3,040,000 shares of Class A Common Stock, $.01 par value, of which 3,040,000
shares are issued and outstanding on the date hereof, (iii) 3,009,600 shares
of Series A Preferred, of which 3,009,600 shares are issued and outstanding
on the date hereof, (iv) 7,246,036 shares of Series B Preferred, of which
7,042,254 shares are issued and outstanding on the date hereof, (v) 4,727,786
shares of Series C Preferred, of which 4,727,786 shares are issued and
outstanding on the date hereof, and (vi) 3,200,000 shares of Series D
Preferred, none of which are issued and outstanding on the date hereof, in
each case without giving effect to the transactions contemplated hereby. A
complete list of the capital shares of the Company which has been previously
issued and the names in which such capital shares are registered on the stock
transfer books of the Company is set forth in EXHIBIT 3.16 hereto. All the
outstanding capital shares of the Company have been duly authorized, are
validly issued and are fully paid and non-assessable. The Purchased Shares,
when issued and delivered in accordance with the terms hereof and after
payment of the purchase price therefor, and the Converted Shares, when issued
and delivered upon conversion of the Purchased Shares, will be duly
authorized, validly issued, fully paid and non-assessable. Except as
otherwise set forth in EXHIBIT 3.16, no options, warrants, subscriptions or
purchase rights of any nature to acquire from the Company shares of capital
stock or other securities are authorized, issued or outstanding, nor is the
Company obligated in any other manner to issue its capital shares or other
securities except as contemplated by this Agreement. Except as set forth in
EXHIBIT 3.16, to the Company's knowledge, there are no restrictions on the
transfer of capital shares of the Company other than those imposed by
relevant Federal and State securities laws and as otherwise contemplated by
this Agreement, the Stockholders' Agreement and the Registration Rights
Agreement. Except as set forth in EXHIBIT 3.16 and other than as provided in
the above-referenced Stockholders' Agreement, to the Company's knowledge,
there are no agreements, understandings, trusts or other collaborative
arrangements or understandings concerning the voting of the capital shares of
the Company. Except as set forth in EXHIBIT 3.16, to the Company's knowledge,
there are no agreements, understandings or trusts concerning transfers of the
capital shares of the Company except for the aforementioned Stockholders'
Agreement, the aforementioned Registration Rights Agreement and except as
contemplated by this Agreement. The offer and sale of all capital shares and
other securities of the Company issued before the Closing complied with or
were exempt from all applicable Federal and State securities laws and no
stockholder has a right of rescission with respect thereto.

         3.16A    CAPITAL STOCK OF SUBSIDIARIES. EXHIBIT 3.16A sets forth a list
of each Subsidiary of the Company and its jurisdiction of incorporation or
organization. The Company owns all of the outstanding capital stock of each of
the Subsidiaries, beneficially and of record, free and clear of all liens,
encumbrances, restrictions (other than those under applicable securities laws)
and claims of every kind. All the outstanding shares of capital stock of each of
the Subsidiaries have been duly authorized, are validly issued and are fully
paid and non-assessable. There are no options, warrants or rights to purchase
shares of capital stock or other securities of any of the Subsidiaries
authorized, issued or outstanding, nor is any Subsidiary obligated in any other
manner to issue shares of its capital stock or other securities.

         3.17     REGISTRATION RIGHTS. Except as set forth in EXHIBIT 3.17 and
except for the rights granted pursuant to the Registration Rights Agreement, no
Person has demand or other rights (which such rights shall be effective
subsequent to the Closing) to cause the Company or any of its Subsidiaries to
file any registration statement under the Securities Act relating to any

                                       10
<PAGE>

securities of the Company or any of its Subsidiaries or any right to participate
in any such registration statement.

         3.18     INSURANCE. EXHIBIT 3.18 sets forth a list (including the name
of the insurer, the name of the policyholder, the periods of coverage and the
scope of coverage) of all material insurance policies under which the Company or
any of its Subsidiaries is a party, a named insured or otherwise the beneficiary
of coverage.

         3.19     BOOKS AND RECORDS. The books of account, ledgers, order books,
records and documents of the Company and each of its Subsidiaries reflect in all
material respects, all material information relating to the business of the
Company and each of its Subsidiaries, the location and collection of their
assets, and the nature of all transactions giving rise to the obligations or
accounts receivable of the Company and each of its Subsidiaries.

         3.20     TITLE TO ASSETS, PATENTS. The Company and each of its
Subsidiaries has good and marketable title in fee to such of its fixed assets,
if any, as are real property, and good and merchantable title to all of its
other assets, free of any mortgages, pledges, charges, liens, security interests
or other encumbrances, except where such failure to so have would not have a
Material Adverse Effect, except as indicated in EXHIBIT 3.20. The Company and
each of its Subsidiaries enjoys peaceful and undisturbed possession under all
leases under which it is operating, and all such leases are valid and subsisting
and in full force and effect. Except as set forth in EXHIBIT 3.20, the Company
knows of no adverse claim that would interfere with its right or the right of
any of its Subsidiaries to use the patents, patent rights, permits, licenses,
trade secrets, trademarks, trademark rights, trade names or trade name rights or
franchises, registered copyrights, inventions, and intellectual property rights
being used to conduct its business as now operated and as now proposed to be
operated (a list of the patent and trademark applications made by the Company
and each of its Subsidiaries is attached hereto as EXHIBIT 3.20); and the
Company has no reason to believe that the conduct of its business or the conduct
of the business of any of its Subsidiaries as now operated and as now proposed
to be operated conflicts or will conflict with valid patents, patent rights,
permits, licenses, trade secrets, trademarks, trademark rights, trade names or
trade name rights or franchises, registered copyrights, inventions, and
intellectual property rights of any other Person, except as noted in EXHIBIT
3.20. To the Company's knowledge, no product or process presently used or
proposed to be manufactured, marketed, offered, sold or used by the Company or
any of its Subsidiaries will violate any license or infringe on any intellectual
property rights of any other Person; and neither the intellectual property
rights of the Company or any of its Subsidiaries nor the operation or proposed
operation of the business of the Company or any of its Subsidiaries is known to
conflict with the asserted rights of others, nor does there exist any known
basis for any such conflict, except as noted in EXHIBIT 3.20. The Company owns
or has the right to use all of the back office and graphic user interface
software necessary to run its website and any graphic or textual content thereof
and, except as set forth in EXHIBIT 3.20, has the right to use and include any
graphic or text on such website free and clear of the intellectual property
rights of any third party. No claim is known to be pending or threatened to the
effect that any such intellectual property owned or licensed by the Company or
any of its Subsidiaries, or which the Company or any of its Subsidiaries
otherwise has the right to use, is invalid or unenforceable by the Company or
any of its Subsidiaries, and the Company has no reason to believe that any
patents or intellectual property rights owned or used by the Company or any of
its Subsidiaries may be invalid. Except as set

                                       11
<PAGE>

forth on EXHIBIT 3.20, neither the Company nor any of its Subsidiaries has any
obligation to compensate any Person for the use of any such patents or rights,
and neither the Company nor any of its Subsidiaries has granted any Person any
license or other rights to use in any manner any of the patents or rights of the
Company or any of its Subsidiaries, whether requiring the payment of royalties
or not. The Company has used commercially reasonable efforts to (i) protect and
enforce all copyright, trademark and patent rights of the Company except for
those copyright, trademark and patent rights that, individually or in the
aggregate, would not have a Material Adverse Effect, and (ii) otherwise secure
and protect for the Company's benefit all of its material rights in its material
intellectual property.

         3.21     REAL PROPERTY HOLDING CORPORATION STATUS. Since its date of
incorporation, neither the Company nor any of its Subsidiaries has been, and as
of the date of the Closing, shall not be, a "United States real property holding
corporation," as defined in Section 897(c)(2) of the Internal Revenue Code, and
in Section 1.897-2(b) of the Treasury Regulations issued thereunder. Neither the
Company nor any of its Subsidiaries have any current plans or intentions which
would cause the Company or any of its Subsidiaries to become a "United States
real property holding corporation," and the Company and each of its Subsidiaries
have filed with the IRS all statements, if any, with its United States income
tax returns which are required under Section 1.897-2(h) of the Treasury
Regulations.

         3.22     LABOR RELATIONS. Except as set forth in the attached EXHIBIT
3.22, (i) there is no labor strike, lock-out, slowdown, or work stoppage
actually pending, or threatened against or affecting the business of the Company
or any of its Subsidiaries; (ii) no labor organization claims to represent the
employees of the Company or any of its Subsidiaries; (iii) neither the Company
nor any of its Subsidiaries is a party to or bound by any collective bargaining
or similar agreement with any labor organization, or work rules or practices
agreed to with any labor organization or employee association applicable to the
employees of the Company or any of its Subsidiaries; (iv) the Company does not
have any knowledge of any current union organizing activities among its
employees nor has there been filed at the National Labor Relations Board any
petition regarding any question concerning representation of such employees; (v)
other than as set forth in the Company's employee handbook (if any), there are
no written personnel policies, rules or procedures applicable to the employees
of the Company or any of its Subsidiaries; (vi) the Company and each of its
Subsidiaries is, and has at all times been, in material compliance with all
applicable laws respecting employment and employment practices, terms and
conditions of employment, wages, hours of work and occupational safety and
health, and is not engaged in any unfair labor practices as defined in the
National Labor Relations Act or other analogous applicable law, ordinance or
regulation; (vii) neither the Company nor any of its Subsidiaries has received
notice of any pending or threatened unfair labor practice charge or complaint
against the Company or any of its Subsidiaries before the National Labor
Relations Board or any similar State or foreign agency; (viii) there is no
grievance arising out of any collective bargaining agreement; (ix) no charges
are pending against the Company or any of its Subsidiaries before the Equal
Employment Opportunity Commission or any other agency responsible for the
prevention of unlawful employment practices; (x) neither the Company nor any of
its Subsidiaries has received notice of the intent of any Federal, State, local
or foreign agency responsible for the enforcement of labor or employment laws to
conduct an investigation nor that any investigation is in progress; and (xi)
neither the Company nor any of its Subsidiaries has received notice of any
pending or threatened complaints, lawsuits or other proceedings in

                                       12
<PAGE>

any forum by or on behalf of any present or former employee, any applicant for
employment or classes of the foregoing alleging breach of any express or implied
contract of employment, any law or regulation governing employment or the
termination thereof or other discriminatory, wrongful or tortious conduct in
connection with the employment relationship, except where such notice would not
have a Material Adverse Effect. Except as set forth in the attached EXHIBIT
3.23(f), there are no employment contracts or severance agreements with any
employees of the Company or any of its Subsidiaries.

         3.23     OTHER AGREEMENTS. Except as set forth in the attached EXHIBITS
3.23 (a) - (p) or in other Exhibits hereto, neither the Company nor any
Subsidiary is a party to any written or oral contract or instrument or other
corporate restriction which, to the best knowledge of the Company, individually
or in the aggregate, could have a Material Adverse Effect. The Company is not in
violation of the terms of any of the agreements listed on EXHIBITS 3.23 (a) -
(p), except where such violation would not result in a Material Adverse Effect.
Neither the Company nor any Subsidiary is a party to any written or oral:

                  (a) distributor, vendor, franchise, dealer or manufacturer's
representative contract or agreement which is not terminable on less than in
ninety (90) days' notice without cost or other liability to the Company or any
Subsidiary (except for contracts which, in the aggregate, are not material to
the business of the Company or Subsidiary, as the case may be), except as set
forth in EXHIBIT 3.23(a);

                  (b) sales contract which entitles any customer to a rebate or
right of set-off, to return any product to the Company or any Subsidiary after
acceptance thereof or to delay the acceptance thereof, or which varies in any
material respect from the Company's standard form contracts or policies, except
as set forth in EXHIBIT 3.23(b);

                  (c) contract with any labor union (and no organizational
effort is being made with respect to any of its employees), except as set forth
in EXHIBIT 3.23(c);

                  (d) contract or other commitment with any supplier containing
any provision permitting any party other than the Company or any Subsidiary to
renegotiate the price or other terms, or containing any pay-back or other
similar provision, upon the occurrence of a failure by either the Company or any
Subsidiary to meet its respective obligations under the contract when due or the
occurrence of any other event, except as set forth in EXHIBIT 3.23(d);

                  (e) contract for the future purchase of fixed assets or for
the future purchase of materials, supplies or equipment in excess of its normal
operating requirements, except as set forth in EXHIBIT 3.23(e);

                  (f) contract for the employment (or separation) of any
officer, individual, employee or other person (whether of a legally binding
nature or in the nature of informal understandings) on a full-time or consulting
basis which is not terminable on notice without cost or other liability to the
Company or any Subsidiary, except accrued vacation pay, except as set forth in
EXHIBIT 3.23(f);

                  (g) bonus, pension, profit-sharing, retirement,
hospitalization, insurance, stock purchase, stock option or similar plan,
contract or understanding pursuant to which benefits are

                                       13
<PAGE>

provided to any employee of the Company or any Subsidiary (other than group
insurance plans applicable to employees generally), except as set forth in
EXHIBIT 3.23(g);

                  (h) agreement or indenture relating to the borrowing of money
or to the mortgaging or pledging of, or otherwise placing a lien or security
interest on, any asset of the Company or any Subsidiary, except as set forth in
EXHIBIT 3.23(h);

                  (i) guaranty of any obligation for borrowed money or otherwise
(other than in the ordinary course of business), except as set forth in EXHIBIT
3.23(i);

                  (j) voting trust, stockholders' agreement, pledge agreement or
buy-sell agreement relating to any securities of the Company or any Subsidiary
which shall be in effect after the Closing except as set forth in EXHIBIT
3.23(j);

                  (k) agreement, or group of related agreements with the same
party or any group of affiliated parties, under which the Company or any
Subsidiary has advanced or agreed to advance money or has agreed to lease any
property as lessee or lessor, except as set forth in EXHIBIT 3.23(k);

                  (l) agreement or obligation (contingent or otherwise) to issue
or sell or to repurchase or otherwise acquire or retire any share of its capital
stock or any of its other equity securities, except as set forth in EXHIBIT
3.23(l);

                  (m) assignment, license or other agreement with respect to any
form of intangible property, except as set forth in EXHIBIT 3.23(m);

                  (n) other contract or group of related contracts with the same
party involving more than $50,000 or continuing over a period of more than six
(6) months from the date or dates thereof (including renewals or extensions
optional with another party), which contract or group of contracts is not
terminable by the Company or any Subsidiary without penalty upon notice of
thirty (30) days or less, but excluding any contract or group of contracts with
a customer of the Company or any Subsidiary for the sale, lease or rental of the
Company's or Subsidiary's products or services if such contract or group of
contracts was entered into by the Company or any Subsidiary in the ordinary
course of business, except as set forth in EXHIBIT 3.23(n);

                  (o) other contract, instrument, commitment, plan or
arrangement, a copy of which would be required to be filed with the Securities
and Exchange Commission as an exhibit to a registration statement on Form S-1 if
the Company or any of its Subsidiaries were registering securities under the
Securities Act, except as set forth in EXHIBIT 3.23(o); or

                  (p) agreement to exercise a buy-out provision of any of the
leases of the Company or any of its Subsidiaries, nor to the Company's
knowledge, is any such agreement or the exercise of any such buy-out provision
presently contemplated, except as set forth in EXHIBIT 3.23(p).

           The Company and each of its Subsidiaries, to the knowledge of the
Company, have in all material respects performed all the material obligations
required to be performed by them to

                                       14
<PAGE>

date, have received no notice of default and are not in default under any lease,
agreement or contract now in effect to which the Company or any Subsidiary is a
party or by which it or its property may be bound, except where such
noncompliance or default would not result in a Material Adverse Effect. Neither
the Company nor any Subsidiary has any present expectation or intention of not
fully performing all its respective material obligations under each such lease,
contract or other agreement, and neither the Company nor any Subsidiary has any
knowledge of any material breach or anticipated breach by the other party to any
contract or commitment to which the Company or any Subsidiary is a party.

         3.24     ENVIRONMENTAL PROTECTION. Except as set forth on EXHIBIT 3.24,
the Company and each of its Subsidiaries, the operation of its business, and any
real property that the Company or any Subsidiary owns, leases or otherwise
occupies or uses (the "Premises") are to the best of the Company's knowledge in
material compliance with all applicable environmental laws and, to the best of
the Company's knowledge, neither the Company nor any Subsidiary is subject to
any liability on account of any environmental laws. To the best of the Company's
knowledge neither the Company nor any Subsidiary has caused or allowed a
release, or a threat of release, of any hazardous substance or petroleum
substance onto, at or near the Premises or any other real property, and, to the
best of the Company's knowledge, the Premises has never been subject to a
release, or a threat of release, of any hazardous substance or petroleum
substance.

         3.25     COMPLIANCE WITH LAW; PERMITS.

                  (a) The Company and each of its Subsidiaries (i) is in
compliance in all material respects with all applicable Federal, State and local
laws, rules, regulations, ordinances and policies; and (ii) is not in default
under any applicable order, writ injunction or decree of any court or
governmental authority having jurisdiction over the Company or any of its
Subsidiaries, except where such default would not result in a Material Adverse
Effect.

                  (b) EXHIBIT 3.25 sets forth a true and complete list of each
material permit, license, order or other authorization of Federal, State, local
or foreign governmental or regulatory bodies held by the Company and each of its
Subsidiaries (other than State corporation qualifications) in the conduct of its
business (collectively the "Permits"), together with the issuing authority and
the date of expiration. To the knowledge of the Company, the Permits constitute
all of the material permits, licenses, orders and other authorizations and
approvals required to permit the Company and each of its Subsidiaries to own and
lease its properties and assets and to conduct its business as it is currently
conducted. All of the Permits are in full force and effect and the Company and
each of its Subsidiaries currently operates within the limits thereof and there
are no proceedings pending or threatened, which could reasonably be expected to
result in the revocation, cancellation, suspension, non-renewal or any material
adverse modification of any of the Permits, except in cases that would not
result in a Material Adverse Effect. The Company and each of its Subsidiaries
has filed all reports and has paid all fees required to obtain and maintain the
Permits.

         3.26     FINANCIAL STATEMENTS. The Company has furnished to each of the
Purchasers a complete and correct copy of the unaudited balance sheet of the
Company at September 30, 1999 and the related unaudited statements of operations
and cash flows for the nine month period then ended (collectively, the
"Financial Statements"). The Financial Statements are complete and

                                       15
<PAGE>

correct in all material respects, are in material conformity with the books and
records of the Company and present fairly in all material respects the financial
condition and results of operations of the Company, at the dates and for the
periods indicated, and have been prepared in accordance with generally accepted
accounting principles ("GAAP") consistently applied.

         3.27     YEAR 2000 COMPLIANCE. The Company has undertaken an assessment
of the Information Technology used by the Company and has made inquiry to all
Material Third Parties regarding their Year 2000 Compliance with respect to
their Information Technology used by the Company. The Company is Year 2000
Compliant except to the extent any such non-compliance would not have a Material
Adverse Effect. Such Material Third Parties claim they are or will become Year
2000 Compliant with respect to their Information Technology used by the Company.
As used in this Section 3.27: (a) the words "Year 2000 Compliant" mean, with
respect to a natural or legal person, that all Information Technology used in
that person's business activities will: (i) accurately process all date and time
data (including, but not limited to, calculating, comparing and sequencing)
including, without limiting the foregoing, between the years 1999 and earlier
and the years 2000 and later (in either direction, forward or backward); (ii)
accurately process leap year calculations for date and time data; and (iii) when
used in combination with any other Information Technology, accurately process
date and time data if the other Information Technology properly exchanges date
and time data with it; (b) the words "Information Technology" mean any and all
systems, facilities and devices by which information (including data, text and
images) is generated, stored, processed, displayed, received or communicated,
including computer hardware and computer software; and (c) the words "Material
Third Party" mean any of the Company's information exchange partners, suppliers
and vendors that own any Information Technology which is material to the
Company's business.

                                   ARTICLE IV

                            COVENANTS OF THE COMPANY

            4.01  AFFIRMATIVE COVENANTS OF THE COMPANY OTHER THAN REPORTING
REQUIREMENTS. Without limiting any other covenants and provisions hereof, the
Company covenants and agrees that until the consummation of a Qualified Public
Offering (as defined in Article VI hereof), it will perform and observe the
following covenants and provisions, and will cause each Subsidiary, if and when
such Subsidiary exists, to perform and observe such of the following covenants
and provisions as are applicable to such Subsidiary:

                  (a) MAINTENANCE OF INSURANCE. Obtain and maintain and cause
each Subsidiary to maintain, from responsible and reputable insurance companies
or associations key person life insurance policies on the lives of any Key
Employee as may be determined (with respect to identity, amount and terms) by
the Board of Directors, with the proceeds thereof payable to the order of the
Company. Maintain, and cause each Subsidiary to maintain, insurance with
responsible and reputable insurance companies or associations in such amounts
and covering such risks as is customarily carried by companies engaged in
similar businesses and owning similar properties in the same general areas in
which the Company or such Subsidiary operates, but in any event in amounts
sufficient to prevent the Company or Subsidiary from becoming a co-insurer
(except as approved by the Board of Directors). The Company will not cause or
permit any assignment of the proceeds of any of the life insurance policies
specified in

                                       16
<PAGE>

the first sentence of this paragraph and will not borrow against such policies.
The Company will, at its expense, use its best efforts to obtain and maintain
directors' and officers' liability insurance in an amount and for premiums which
are on commercially reasonable terms for comparable companies as determined by
the Board of Directors.

                  (b) PRESERVATION OF CORPORATE EXISTENCE. Preserve and
maintain, and cause each Subsidiary to preserve and maintain, its corporate
existence, rights and privileges in the jurisdiction of its incorporation, and
qualify and remain qualified, and cause each Subsidiary to qualify and remain
qualified, as a foreign corporation in each jurisdiction in which such
qualification is necessary or desirable in view of its business and operations
or the ownership or lease of its properties. Secure, preserve and maintain, and
cause each Subsidiary to secure, preserve and maintain, all licenses and other
rights to use patents, processes, licenses, permits, trademarks, trade names,
inventions, intellectual property rights or copyrights owned or possessed by it
and deemed by the Company to be necessary to the conduct of its business or the
business of any Subsidiary, as the case may be.

                  (c) INSPECTION. Permit, upon reasonable request and notice,
during normal business hours and without disruption of the Company's business,
each of the Purchasers or any agents or representatives thereof, to examine and
make copies of and extracts from the records and books of account of, and visit
and inspect the properties of the Company and any Subsidiary, to discuss the
affairs, finances and accounts of the Company and any Subsidiary with any of its
officers, directors or Key Employees and independent accountants, and consult
with and advise the management of the Company and any Subsidiary as to their
affairs, finances and accounts, all at reasonable times. Each Purchaser agrees
that it will use its best efforts to maintain the confidentiality of any
information so obtained by it which is not otherwise available from other
sources (and will use its best efforts to prevent such confidential information
from becoming known to the Company's competitors), subject to the disclosure of
information of a non-technical nature, including financial information, which
such Purchaser discloses to its partners and/or shareholders generally.

                  (d) KEEPING OF RECORDS AND BOOKS OF ACCOUNT. Keep, and cause
each Subsidiary to keep, adequate records and books of account in which complete
entries will be made in accordance with generally accepted accounting principles
consistently applied, reflecting all financial transactions of the Company and
any Subsidiary.

                  (e) BUDGETS APPROVAL. Not later than thirty (30) days prior to
the commencement of each fiscal year, prepare and submit to, and obtain the
approval of a majority of, the Board of Directors, an annual budget with monthly
operating budgets in detail for such fiscal year, including capital and
operating expense budgets, cash flow projections and profit and loss
projections, all itemized in reasonable detail (including itemization of
provisions for officers' compensation).

                  (f) STOCK RESTRICTION AGREEMENTS. If any officer, employee or
consultant (including each Key Employee) receives any shares of Class B Common
Stock or rights or options to purchase shares of Class B Common Stock pursuant
to a stock purchase or option plan or other employee stock incentive program,
cause each such officer, employee and consultant to

                                       17
<PAGE>

execute and deliver an agreement in a form as deemed appropriate by the
affirmative vote of a majority of the members of the Board of Directors.

                  (g) THE BOARD OF DIRECTORS. Call and, to the extent a quorum
can be maintained, hold a meeting of the Company's Board of Directors at least
every six weeks; unless otherwise approved by the Board of Directors. Promptly
pay all out-of-pocket expenses reasonably incurred by each director of the Board
of Directors of the Company in attending each meeting of the Board of Directors
or any committee thereof.

                  (h) CHECK SIGNING. Require the signature of at least two
officers of the Company on any single check equal to or greater than $25,000 or
such larger amount as is set by the Company's Board of Directors from time to
time.

                  (i) COMPENSATION. Provide to the Board of Directors
information regarding proposed (i) option grants to employees, consultants and
directors; and (ii) compensation and fringe benefits, both direct and indirect,
of all Key Employees, all vice presidents, all consultants (other than
consultants to whom total consideration during any year does not exceed
$250,000) and all directors of the Company and each Subsidiary, for advance
approval by the Board of Directors prior to or at the next scheduled Board
meeting thereafter, so informing those employees, consultants, or directors of
such proposed option grant, compensation or fringe benefit; provided that all
such proposed compensation and fringe benefits offered prior to Board approval
shall be contingent upon such Board approval.

                  (j) AVAILABLE SHARES. At all times, reserve and keep available
out of its authorized but unissued shares of Class B Common Stock, for the
purpose of effecting the conversion of the Purchased Shares, such number of its
duly authorized shares of Class B Common Stock as shall be sufficient to effect
the conversion of the Purchased Shares from time to time outstanding. If at any
time the number of authorized but unissued shares of Class B Common Stock shall
not be sufficient to effect the conversion of the Purchased Shares, the Company
shall take such corporate action as may be necessary to increase its authorized
but unissued shares of Class B Common Stock as shall be sufficient for such
purposes. The Company will obtain any authorization, consent, approval or other
action by or make any filing with any court or administrative body which may be
required under applicable state securities laws in connection with the issuance
of shares of Class B Common Stock upon conversion of the Purchased Shares.

                  (k) NON-DISCLOSURE AGREEMENTS. The Company shall use its best
efforts to obtain an Assignment of Inventions and Non-Disclosure Agreement in
such form as is approved by the Board of Directors, from all officers, key
employees or other employees who will have access to confidential information of
the Company or any of its Subsidiaries, upon their employment by the Company or
any of its Subsidiaries.

         4.02     NEGATIVE COVENANTS OF THE COMPANY. Without limiting any other
covenants and provisions hereof, the Company covenants and agrees that, until
the consummation of a Qualified Public Offering, it will comply with and observe
the following covenants and provisions, and will cause each Subsidiary, if and
when such Subsidiary exists, to comply with and observe such of the following
covenants and provisions as are applicable to such Subsidiary,

                                       18
<PAGE>

and will not, without the consent of the holders of at least 50% in interest of
the Series A Preferred, the Series B Preferred, Series C Preferred and Series D
Preferred, voting together as a single class:

                  (a) INDEBTEDNESS. Except as set forth on EXHIBIT 4.02(a),
create, incur, assume or suffer to exist, or permit any Subsidiary to create,
incur, assume or suffer to exist, any liability with respect to (i) Indebtedness
(excluding letters of credit or indemnities for letters of credit issued by
others) for money borrowed which exceeds in the aggregate $1,000,000, or (ii)
without the prior approval of a majority of the members of the Board of
Directors, Indebtedness in respect of lease obligations which exceeds in the
aggregate $300,000.

                  (b) MERGER OR SALE. Merge or consolidate with or into any
other entity, sell or lease to any person or entity any assets constituting all
or substantially all of the assets of the Company, or agree to do or permit any
Subsidiary to do any of the foregoing, except that any wholly owned Subsidiary
may merge into or consolidate with the Company or with or into any other wholly
owned Subsidiary.

                  (c) ASSUMPTIONS OR GUARANTIES OF INDEBTEDNESS OF OTHER
PERSONS. Assume, guarantee, endorse or otherwise become directly or contingently
liable on, or permit any Subsidiary to assume, guarantee, endorse or otherwise
become directly or contingently liable on (including, without limitation,
liability by way of agreement, contingent or otherwise, to purchase, to provide
funds for payment, to supply funds to or otherwise invest in the debtor or
otherwise to assure the creditor against loss) any Indebtedness of any other
Person, except for guaranties by endorsement of negotiable instruments for
deposit or collection in the ordinary course of business and except for the
guaranties of the permitted obligations of any wholly owned Subsidiary.

                  (d) DISTRIBUTIONS. Except as required by the Company's
Restated Certificate of Incorporation, declare or pay any dividends, purchase,
redeem, retire, or otherwise acquire for value any of its capital stock (or
rights, options or warrants to purchase such shares) now or hereafter
outstanding, return any capital to its stockholders as such, or make any
distribution of assets to its stockholders as such, or permit any Subsidiary to
do any of the foregoing (such transactions being hereinafter referred to as
"Distributions"), EXCEPT that any such Subsidiary may declare and make payment
of cash and stock dividends, return capital and make distributions of assets to
the Company, PROVIDED, HOWEVER, that nothing herein contained shall prevent the
Company from:

                        (i)  effecting a stock split (except for a reverse stock
      split), or

                        (ii) redeeming any shares of a deceased stockholder out
      of insurance held by the Company on that stockholder's life, or

                        (iii) repurchasing, at the original purchase price of
      such shares, any shares of the Company's capital stock held by officers,
      employees, directors or consultants of the Company which are subject to
      restrictive stock purchase agreements under which the Company is entitled
      to repurchase such shares upon the occurrence of certain events, including
      the termination of employment,

                                       19
<PAGE>

      if in the case of any such transaction the payment can be made in
      compliance with the other terms of this Agreement.

                  (e) CHANGE IN NATURE OF BUSINESS.  Make or permit any
Subsidiary to make, any material change in the nature of its business as
contemplated in written materials delivered to the Purchasers prior to the
date hereof.

                  (f) OWNERSHIP OF SUBSIDIARIES. Without the prior approval
of the Board of Directors, purchase or hold beneficially any stock, other
securities or evidences of Indebtedness in, or make any investment in or
provide any extension of credit to any other Person, excluding a wholly-owned
or controlled subsidiary of the Company.

                  (g) CAPITAL EXPENDITURES. Except as set forth on EXHIBIT
4.02(g), incur any Capital Expenditures (as defined in Article VI hereof) with
respect to a single item, asset, store, commissary or project in excess of
$500,000 or exceed the projections for Capital Expenditures contained in the
Business Plan by more than twenty-five percent (25%).

                  (h) DEALINGS WITH AFFILIATES AND OTHERS. Other than as
contemplated by this Agreement or set forth in EXHIBIT 4.02(h), and other than
arms-length transactions in the ordinary course of business involving less than
$5,000, enter into any transaction, including, without limitation, any loans or
extensions of credit or royalty agreements, with any officer or director of the
Company or any Subsidiary or holder of any class of capital shares of the
Company, or any member of their respective immediate families or any corporation
or other entity directly or indirectly affiliated with one or more of such
officers, directors or stockholders or members of their immediate families
unless such transaction is approved in advance by a majority of the members of
the Board of Directors who have no interest in such transaction, or absent such
Board of Directors approval, by all of the Purchasers.

                  (i) COMPENSATION. Unless approved by a majority of the members
of the Board of Directors, issue or authorize for issuance any Reserved
Management Shares (including options for the purchase thereof), or increase by
more than ten percent (10%) in any calendar year the salary and/or bonus of any
Key Employee or any vice president of the Company or any Subsidiary.

                  (j) INVESTMENT IN OTHER CORPORATIONS. Make or permit any
Subsidiary to make, any loan or advance to any Person in excess of $250,000, or
purchase, otherwise acquire, or permit any Subsidiary to purchase or otherwise
acquire, the capital stock, assets comprising the business of, obligations of,
or any interest in, any other corporation or entity.

                  (k) VESTING OF RESERVED MANAGEMENT SHARES. Grant to any of its
employees options or other rights to purchase Reserved Management Shares which
will become exercisable or vest, as the case may be, at a rate in excess of 25%
per annum from the date of hire by the Company or any Subsidiary unless
otherwise authorized by the Board of Directors.

                  (l) ISSUANCE OF RESERVED MANAGEMENT SHARES.  Issue any
shares (or any options to purchase shares) of Class B Common Stock which are
Reserved Management Shares in excess of 4,500,000 shares.

                                       20
<PAGE>

                  (m) CONSIDERATION FOR ISSUANCES OF COMMON STOCK. Except as set
forth in EXHIBIT 4.02(M), issue, sell or exchange, agree to issue, sell or
exchange, or reserve or set aside for issuance, sale or exchange, shares of its
Common Stock, or any securities convertible into Common Stock, without
consideration or for non-cash consideration; except for (i) Common Stock issued
upon any subdivision or combination of shares of Common Stock, (ii) the issuance
of any Converted Shares or (iii) the issuance of Reserved Management Shares.

                  (n) FURNITURE SHOWROOMS. Without the consent of a majority of
the Board of Directors, purchase any additional furniture showrooms.

                  (o)  KEY EMPLOYEES.  Terminate the employment of any Key
Employee of the Company or any vice president of the Company or any Subsidiary
without the prior approval of a majority of the Board of Directors.

         4.03.    REPORTING REQUIREMENTS.  Until the consummation of a Qualified
Public Offering, the Company will furnish the following to each person who holds
any of the Shares:

                  (a) MONTHLY REPORTS: as soon as available and in any event
within thirty (30) days after the end of each calendar month (excluding fiscal
quarter and year ending months addressed in subparagraphs (b) and (c) below),
consolidated and consolidating balance sheets of the Company and its
Subsidiaries as of the end of such month and consolidated and consolidating
statements of income and retained earnings of the Company and its Subsidiaries
for such month and for the period commencing at the end of the previous fiscal
year and ending with the end of such month, setting forth in each case in
comparative form the corresponding figures for the corresponding period of the
preceding fiscal year, and including comparisons to monthly budgets, a summary
of the Company's aging accounts receivable and accounts payable, a cash flow
analysis for such month, a schedule showing each expenditure of a capital nature
in excess of $50,000 during such month, detail of sales and profits for such
month and the year-to-date, all in reasonable detail and duly certified by the
chief financial officer of the Company as having been prepared in accordance
with generally accepted accounting principles consistently applied (except for
year-end adjustments and the absence of footnotes);

                  (b) QUARTERLY REPORTS: as soon as available and in any event
within sixty (60) days after the end of each of the first three (3) quarters of
each fiscal year of the Company, consolidated and consolidating balance sheets
of the Company and its Subsidiaries as of the end of such quarter and
consolidated and consolidating statements of income and retained earnings and
cash flows of the Company and its Subsidiaries for such quarter and for the
period commencing at the end of the previous fiscal year and ending with the end
of such quarter, setting forth in each case in comparative form the
corresponding figures for the corresponding period of the preceding fiscal year,
and including comparisons to quarterly budgets and a summary discussion of the
Company's principal functional areas, all in reasonable detail and duly
certified (subject to year-end audit adjustments and the absence of footnotes)
by the chief financial officer of the Company as having been prepared in
accordance with generally accepted accounting principles consistently applied;

                  (c) ANNUAL REPORTS: as soon as available and in any event
within 120 days after the end of each fiscal year of the Company, a copy of the
annual audit report for such year

                                       21
<PAGE>

for the Company and its Subsidiaries, including therein consolidated and
consolidating balance sheets of the Company and its Subsidiaries as of the end
of such fiscal year and consolidated and consolidating statements of income and
retained earnings and of changes in the financial position of the Company and
its Subsidiaries for such fiscal year, setting forth in each case in comparative
form the corresponding figures for the preceding fiscal year, all such
consolidated statements to be duly certified by the chief financial officer of
the Company and by such independent public accountants of recognized national
standing as have been approved by a majority of the Board of Directors;

                  (d) BUDGETS:  as soon as available after approval by the Board
of Directors, a business plan and monthly operating budgets for the forthcoming
fiscal year;

                  (e) NOTICE OF ADVERSE CHANGES: promptly after the occurrence
thereof and in any event within thirty (30) Business Days after such occurrence
is known to the Company, notice of any material adverse change in the operations
or financial condition of the Company or any material default in any other
material agreement to which the Company is a party;

                  (f) WRITTEN REPORTS: promptly upon receipt or publication
thereof, any written reports submitted to the Company by independent public
accountants in connection with an annual or interim audit of the books of the
Company and its Subsidiaries made by such accountants or by consultants or other
experts in connection with such consultant's or other expert's review of the
Company's operations or industry, and written reports prepared by the Company to
comply with other investment or loan agreements;

                  (g) NOTICE OF PROCEEDINGS: promptly after the commencement
thereof, notice of all actions, suits and proceedings before any court or
governmental department, commission, board, bureau, agency or instrumentality,
domestic or foreign, affecting the Company or any Subsidiary of the type
described in Section 3.04;

                  (h) STOCKHOLDERS' AND SEC REPORTS: promptly upon sending,
making available, or filing the same, such reports and financial statements as
the Company or any Subsidiary shall send or make available to the stockholders
of the Company or file with the Securities and Exchange Commission; and

                  (i) OTHER INFORMATION: such other information respecting the
business, properties or the condition or operations, financial or otherwise, of
the Company or any of its Subsidiaries as any holder of the Shares may from time
to time reasonably request.

                                       22
<PAGE>

                                    ARTICLE V

                             RIGHT OF FIRST REFUSAL

         5.01. RIGHT OF FIRST REFUSAL. The Company shall not issue, sell or
exchange, agree or obligate itself to issue, sell or exchange, or reserve or set
aside for issuance, sale or exchange, any (i) shares of Class A Common Stock,
(ii) shares of Class B Common Stock, (iii) any other equity security of the
Company, including without limitation, shares of Series A Preferred, Series B
Preferred, Series C Preferred or Series D Preferred, (iii) any debt security of
the Company (other than a bank line of credit or other Indebtedness for borrowed
money from an institutional lender, in each case with no equity feature)
including without limitation, any debt security which by its terms is
convertible into or exchangeable for any equity security of the Company, (iv)
any security of the Company that is a combination of debt and equity, or (v) any
option, warrant or other right to subscribe for, purchase or otherwise acquire
any such equity security or any such debt security of the Company, unless in
each case the Company shall have first offered to sell such securities (the
"Offered Securities") to the holders of the Series A Preferred, Series B
Preferred, Series C Preferred and the Purchasers (together, the "Investors") as
follows: The Company shall offer to sell to each Investor (a) that number of
such securities so that, after giving effect to such issuance, such Investor
will continue to maintain its same proportionate equity ownership in the Company
as of the date of such notice on a fully diluted basis assuming the shares
reserved for issuance upon the exercise of options have been issued (the "Basic
Amount"), and (b) such additional portion of the Offered Securities as such
Investor shall indicate it will purchase should the other Investors subscribe
for less than their Basic Amounts (the "Undersubscription Amount"), at a price
and on such other terms as shall have been specified by the Company in writing
delivered to such Investor (the "Offer"), which Offer by its terms shall remain
open and irrevocable for a period of twenty (20) days from receipt of the offer.

         5.02. NOTICE OF ACCEPTANCE. Notice of each Investor's intention to
accept, in whole or in part, any Offer made pursuant to Section 5.01 shall be
evidenced by a writing signed by such Investor and delivered to the Company
prior to the end of the 20-day period of such offer, setting forth such of the
Investor's Basic Amount as such Investor elects to purchase and, if such
Investor shall elect to purchase all of its Basic Amount, any Undersubscription
Amount as such Investor shall elect to purchase (the "Notice of Acceptance"). If
the Basic Amounts subscribed for by all Investors are less than the total
Offered Securities, then each Investor who has set forth Undersubscription
Amounts in its Notice of Acceptance shall be entitled to purchase, in addition
to the Basic Amounts subscribed for, all Undersubscription Amounts it has
subscribed for; PROVIDED, HOWEVER, that should the Undersubscription Amounts
subscribed for exceed the difference between the Offered Securities and the
Basic Amounts subscribed for (the "Available Undersubscription Amount"), each
Investor who has subscribed for any Undersubscription Amount shall be entitled
to purchase only that portion of the Available Undersubscription Amount as the
Undersubscription Amount subscribed for by such Investor bears to the total
Undersubscription Amounts subscribed for by all Investor, subject to rounding by
the Board of Directors to the extent it reasonably deems necessary.

                                       23
<PAGE>

         5.03.    CONDITIONS TO ACCEPTANCES AND PURCHASE.

                  (a) PERMITTED SALES OF REFUSED SECURITIES. In the event that
Notices of Acceptance are not given by the Investors in respect of all the
Offered Securities, the Company shall not be obligated to sell the part of such
Offered Securities as to which a Notice of Acceptance has not been given by the
Investors (the "Refused Securities"), and the Company shall have 120 days from
the expiration of the period set forth in Section 5.01 to sell all or any part
of the Refused Securities to the Person or Persons specified in the Offer, but
only in all respects upon terms and conditions, including, without limitation,
unit price and interest rates, which are no more favorable, in the aggregate, to
such other Person or Persons or less favorable to the Company than those set
forth in the Offer.

                  (b) REDUCTION IN AMOUNT OF OFFERED SECURITIES. In the event
the Company shall propose to sell less than all the Refused Securities (any such
sale to be in the manner and on the terms specified in Section 5.03(a) above),
then each Investor may, at its sole option and in its sole discretion, reduce
the number of, or other units of the Offered Securities specified in its
respective Notices of Acceptance to an amount which shall be less than the
amount of the Offered Securities which the Investor elected to purchase pursuant
to Section 5.02 multiplied by a fraction, (i) the numerator of which shall be
the amount of Offered Securities which the Company actually proposes to sell,
and (ii) the denominator of which shall be the amount of all Offered Securities.
In the event that any Investor so elects to reduce the number or amount of
Offered Securities specified in its respective Notices of Acceptance, the
Company may not sell or otherwise dispose of more than the reduced amount of the
Offered Securities until such securities have again been offered to the
Investors in accordance with Section 5.01.

                  (c) CLOSING. Upon the closing of the sale to such other Person
or Persons of all or less than all of the Refused Securities, the Investors
shall purchase from the Company, and the Company shall sell to the Investors
(upon full payment for such shares), the number of Offered Securities specified
in the Notices of Acceptance, as reduced pursuant to Section 5.03(b) if the
Investors have so elected, upon the terms and conditions specified in the Offer.
The purchase by the Investors of any Offered Securities is subject in all cases
to the preparation, execution and delivery by the Company and the Investors of a
purchase agreement relating to such Offered Securities reasonably satisfactory
in form and substance to the Investors and their counsel.

         5.04. FURTHER SALE. In each case, any Offered Securities not purchased
by the Investors or other Person or Persons in accordance with Section 5.03 may
not be sold or otherwise disposed of until they are again offered to the
Investors under the procedures specified in Sections 5.01, 5.02 and 5.03.

         5.05. TERMINATION OF RIGHT OF FIRST REFUSAL.  The rights of the
Investors under this Article V shall terminate immediately prior to the
consummation of a Qualified Public Offering.

         5.06. EXCEPTION.  The rights of the Investors under this Article V
shall not apply to:

                  (a) up to 4,500,000 shares of Class B Common Stock (as
adjusted for a stock splits and the like) or options exercisable therefor,
issued or issuable to officers, employees or

                                       24
<PAGE>

consultants for the Company or any Subsidiary pursuant to the Company's 1998
Stock Incentive Plan or other stock incentive plan;

                  (b) equity securities of the Company issued pursuant to the
acquisition of another corporation by the Company by merger (whereby the Company
owns no less than fifty-one percent (51%) of the voting power of such
corporation) or purchase of substantially all of its stock or assets;

                  (c) the Converted Shares;

                  (d) the issuance of shares of Series B Preferred upon exercise
of the Comdisco Warrants, or the issuance of shares of Class B Common Stock upon
conversion of the shares of Series B Preferred issued upon exercise of the
Comdisco Warrants;

                  (e) the issuance of shares of Class B Common Stock upon
conversion of the shares of Class A Common Stock outstanding as of the date of
this Agreement;

                  (f) the issuance of shares of Class B Common Stock upon
conversion of the shares of Series B Preferred outstanding as of the date of
this Agreement;

                  (g) the issuance of shares of Class B Common Stock upon
conversion of the shares of Series C Preferred outstanding as of the date of
this Agreement; or

                  (h) the issuance of shares of Class B Common Stock upon the
conversion of the shares of Series D Preferred issued pursuant to this
Agreement.

         5.07.     FIRST QUALIFIED PUBLIC OFFERING.

                  (a) RIGHT OF FIRST REFUSAL. Notwithstanding the provisions of
Section 5.05 of this Agreement but subject to the limitations set forth in
Section 5.06 and this Section 5.07, Purchasers holding Series C Preferred have
rights of first refusal that were granted to them pursuant to that Series C
Preferred Stock Purchase Agreement, dated as of June 23, 1999, (which right is
restated herein and shall be governed by the terms of this Agreement) to
purchase such Purchaser's Proportionate Share of the shares of Class B Common
Stock from the shares of Class B Common Stock to be issued at the closing of the
Company's first Qualified Public Offering, if any. The price per share of Class
B Common Stock which each such Purchaser becomes entitled to purchase by reason
hereof shall be the public offering price per share of Class B Common Stock in
such Qualified Public Offering (the "Offering Price").

                  (b) LIMITATIONS. Subject to the limitations set forth in the
following sentence, the "Proportionate Share" for each such Purchaser shall be
that number of shares of the Class B Common Stock to be issued in such Qualified
Public Offering necessary so that, after giving effect to such issuance, such
Purchaser will continue to maintain its same proportionate equity ownership in
the Company, as of the date immediately prior to the effective date of the
registration statement covering such Qualified Public Offering, on a fully
diluted basis assuming, among other things, the shares reserved for issuance
upon the exercise of options have been issued. Notwithstanding the foregoing
sentence, such Proportionate Share, in the aggregate for all Purchasers, may not
exceed 8% of the number of shares of Class B Common Stock issued by

                                       25
<PAGE>

the Company in such Qualified Public Offering (exclusive of the number of shares
of Class B Common Stock issued pursuant to any underwriter's overallotment
option); PROVIDED, HOWEVER, the managing underwriter of such offering shall be
entitled to reduce in whole or in part the Proportionate Share to the extent
determined necessary by the managing underwriter in its sole discretion (X) to
the success of such offering (including without limitation that purchase by a
Purchaser of its Proportionate Share would adversely affect any of the offering
price, offering size, likelihood of completion or completion date) for reasons
set forth in writing to the Purchasers no less than five days prior to the
anticipated effective date of the registration statement covering such offering
or (Y) to comply with the rules or regulations of the Securities and Exchange
Commission, the National Association of Securities Dealers, Inc., the Nasdaq
Stock Market, Inc., or other regulatory body or exchange for reasons set forth
in writing to the requesting Purchasers no less than one day prior to the
anticipated effective date of the registration statement covering such offering.
Any reduction (in whole or in part) in any Purchaser's Proportionate Share shall
be PRO RATA among the Purchasers expressing an interest in receiving an offer
from the Company in accordance with subsection 5.07(d) below (the "IPO
Purchasers") based upon the number of Shares then held by the IPO Purchasers.

                  (c) SOLICITATION OF INTEREST. Except as (and to the extent)
prohibited by law, the Company shall, no less than one day prior to the
anticipated effective date of the registration statement covering such Qualified
Public Offering, deliver by facsimile transmission to the Purchasers holding
Series C Preferred a notice (a "Solicitation of Interest") with respect to such
Qualified Public Offering stating the Company's bona fide intention to offer
shares of Class B Common Stock in such Qualified Public Offering. The Company
shall send the Solicitation of Interest to each such Purchaser at the fax number
for such Purchaser set forth in the Company's corporate records or such other
fax number that such Purchaser shall from time to time specify in writing to the
Company.

                  (d) EXPRESSION OF INTEREST. Each such Purchaser shall, on or
before 5:00 p.m. (Boston time) on the immediately succeeding business day after
receipt of the Solicitation of Interest (the "Expression of Interest Deadline"),
by facsimile transmission to the Company and its counsel, notify the Company of
its desire (an "expression of interest") in receiving an offer to purchase (i)
all or part of its Proportionate Share (specifying, if less than its
Proportionate Share, the number of shares it desires to receive an offer to
purchase) and (ii) a number of shares, if any, in excess of such Purchaser's
Proportionate Share that it desires to receive an offer to purchase (the "Excess
Shares"), subject in each case to the limitations set forth in this Section
5.07. A Purchaser shall be deemed to have waived its right to receive an offer
to purchase any of the shares in such Qualified Public Offering if the Company
does not receive the Purchaser's expression of interest as aforesaid by the
Expression of Interest Deadline. The Company may, during the 60-day period after
expiration of the Expression of Interest Deadline, either solicit expression of
interests from any person or persons with respect to that portion of such Class
B Common Stock for which the such Purchasers have not made an expression of
interest or determine not to offer or sell such portion, in whole or in part;
PROVIDED, HOWEVER, if the Company does not consummate the sale of the Shares in
such Qualified Public Offering within 60 days of the Solicitation of Interest,
the right provided hereunder shall be deemed revived as to all Purchasers
holding Series C Preferred. If any Purchaser expresses an interest in receiving
an offer to purchase a number of shares that is less than its Proportionate
Share (or is deemed to waive its right to receive an offer to purchase its
Proportionate Share in such Qualified Public

                                       26
<PAGE>

Offering), each IPO Purchaser requesting Excess Shares, if any, shall be
entitled to receive an offer from the Company for that number of additional
shares equal to the lesser of (A) the number of Excess Shares with respect to
which such IPO Purchaser expressed an interest and (B) such IPO Purchaser's
allocable portion of all Excess Shares based on the respective equity ownership
in the Company (determined as of the date immediately prior to the effective
date of the registration statement covering such Qualified Public Offering on a
fully diluted basis assuming, among other things, the shares reserved for
issuance upon the exercise of options and warrants have been issued) by all IPO
Purchasers who expressed an interest in receiving an offer to purchase Excess
Shares.

                  (e) An IPO Purchaser's notification pursuant to subsection
5.07(d) shall be deemed an expression of interest in receiving an offer by the
Company to purchase the number of shares of Class B Common Stock indicated by
such IPO Purchaser pursuant to subsection 5.07(d) above (including any Excess
Shares), in each case subject to the limitations set forth in this Section 5.07.
The Company's offer to sell such shares to the IPO Purchasers shall be deemed to
occur automatically two hours after the latest to occur of (A) the effectiveness
of the registration statement covering such Qualified Public Offering and (B)
the Company's determination of the Offering Price (the completion of the last to
occur of the foregoing, the "Offer Commencement"). Each IPO Purchaser shall have
an unconditional right to withdraw its expression of interest by written notice
to the Company on or before the Offer Commencement. Once so withdrawn, the
Company shall have no obligation to offer or to sell, and the IPO Purchaser
shall have no obligation to purchase, any shares. An IPO Purchaser's expression
of interest shall, unless so withdrawn by such IPO Purchaser on or before the
Offer Commencement, automatically be deemed to be a binding commitment to
purchase the shares of Class B Common Stock, including any Excess Shares,
indicated by such IPO Purchaser pursuant to subsection 5.07(d) above, but
subject to the limitations set forth in this Section 5.07 immediately after the
Offer Commencement. The IPO Purchasers' purchase of such shares shall occur
simultaneously with the closing of the purchase and sale of the other shares of
Class B Common Stock distributed in such Qualified Public Offering pursuant to a
stock purchase agreement in form satisfactory to the Company, and each IPO
Purchaser shall thereat pay the purchase price for its shares by wire transfer
to the Company of immediately available funds. As promptly as practicable (and
in any event within ten days) thereafter, the Company shall issue and deliver to
each IPO Purchaser at the last known address of the IPO Purchaser in the records
of the Company a certificate or certificates for such shares.

                  (f) Notwithstanding anything in this Agreement to the
contrary, the Company shall not be required to take any actions pursuant to this
Section 5.07 that would be inconsistent with any federal or state securities
laws, rules, regulations or interpretations (including without limitation Rule
134 under the Securities Act) or the rules or regulations of the National
Association of Securities Dealers, Inc., the Nasdaq Stock Market, Inc. or other
regulatory body or exchange.

                  (g) The rights of the Purchasers under this Section 5.07 shall
terminate upon the earlier of (i) immediately after the Offer Commencement
(assuming the Company has complied with its obligations in this Section 5.07)
and (ii) immediately prior to the sale of all or substantially all of the assets
or business of the Company, by merger, sale of assets or otherwise.

                                       27
<PAGE>

                  (h) The Purchasers agree that none of the Company or its
officers, directors, employees, shareholders, affiliates, successors,
transferees, assigns, agents or representatives or any underwriter shall have
any liability to the Purchasers arising in connection with any reduction or
elimination of any Proportionate Share taken in accordance with subsection
5.07(b) except to the extent arising out of the Company's bad faith.

                                   ARTICLE VI

                        DEFINITIONS AND ACCOUNTING TERMS

         6.01.    CERTAIN DEFINED TERMS.  As used in this Agreement, the
following terms shall have the following meanings (such meanings to be equally
applicable to both the singular and plural forms of the terms defined):

         "Additional Purchaser" shall have that meaning attributable to it in
Section 2(b) of this Agreement.

         "Agreement" means this Series D Preferred Purchase Agreement as from
time to time amended and in effect between the parties, including all Exhibits
hereto.

         "Board of Directors" means the board of directors of the Company as
constituted from time to time.

         "Capital Expenditures" for any period shall mean all amounts debited or
required to be debited to the fixed asset accounts on the balance sheet of the
Company during such period in accordance with generally accepted accounting
principles in respect of (a) the acquisition, development or improvement of any
computer hardware, software or equipment, (b) the acquisition, construction,
improvement, replacement or betterment of land, buildings, machinery, equipment
or of any other fixed assets or leaseholds, and (b) to the extent related to and
not included in (a) or (b) above, materials, contract labor and direct labor
(excluding expenditures properly chargeable to repairs or maintenance in
accordance with generally accepted accounting principles).

         "Class A Common Stock" means the Company's Class A Common Stock, $.01
par value, as authorized as of the date of this Agreement, having the rights,
powers, privileges and preferences set forth in EXHIBIT 1.01A hereto.

         "Class B Common Stock" includes (a) the Company's Class B Common Stock,
$.01 par value, as authorized as of the date of this Agreement, having the
rights, powers, privileges and preferences set forth in EXHIBIT 1.01A, (b) any
other capital shares of any class or classes (however designated) of the
Company, authorized on or after the date hereof, the holders of which shall have
the right, without limitation as to amount, either to all or to a share of the
balance of current dividends and liquidating dividends after the payment of
dividends and distributions on any shares entitled to preference, and the
holders of which shall ordinarily, in the absence of contingencies or in the
absence of any provision to the contrary in the Company's Restated Certificate
of Incorporation, be entitled to vote for the election of a majority of
directors

                                       28
<PAGE>

of the Company (even though the right so to vote has been suspended by the
happening of such a contingency or provision), and (c) any other securities into
which or for which any of the securities described in (a) or (b) may be
converted or exchanged pursuant to a plan of recapitalization, reorganization,
merger, sale of assets or otherwise.

         "Comdisco Warrants" means the warrants to purchase up to 202,465 shares
of Series B Preferred which the Company may issue to Comdisco, Inc. in
connection with subordinated debenture financing and capital lease transactions.

         "Company" means and shall include Furniture.com, Inc., a Delaware
corporation, and its successors and assigns.

         "Consolidated" and "consolidating" when used with reference to any term
defined herein mean that term as applied to the accounts of the Company and its
Subsidiaries consolidated in accordance with generally accepted accounting
principles.

         "Converted Shares" means those shares of Class B Common Stock into
which shares of Series D Preferred are convertible pursuant to the terms of the
Company's Restated Certificate of Incorporation.

         "ERISA" means the Employee Retirement Income Security Act of 1974, as
amended.

         "GAAP" means in accordance with United States generally accepted
accounting principles, consistently applied.

         "Indebtedness" means all obligations, contingent and otherwise, which
should, in accordance with generally accepted accounting principles, be
classified upon the obligor's balance sheet (or the notes thereto) as
liabilities, but in any event including liabilities secured by any mortgage on
property owned or acquired subject to such mortgage, whether or not the
liability secured thereby shall have been assumed, and also including (i) all
guaranties, endorsements and other contingent obligations, in respect of
Indebtedness of others, whether or not the same are or should be so reflected in
said balance sheet (or the notes thereto), except guaranties by endorsement of
negotiable instruments for deposit or collection or similar transactions in the
ordinary course of business and (ii) the present value of any lease payments due
under leases required to be capitalized in accordance with applicable Statements
of Financial Accounting Standards, determined by discounting all such payments
at the interest rate determined in accordance with applicable Statements of
Financial Accounting Standards.

         "Key Employee" means and includes Andrew Brooks and any other
individual as may be reasonably designated by the Board of Directors of the
Company.

         "Knowledge," "to the best of knowledge," "known," and any other words
of similar import as used with respect to representations and warranties by the
Company shall mean those matters or facts which are actually known or, upon
reasonable investigation should be known, by any Key Employee.

                                       29
<PAGE>

         "Material Adverse Effect" means a material adverse effect on the
business, assets, condition (financial or otherwise) or results of operations of
the Company or any Subsidiary, taken as a whole.

         "Person" means an individual, corporation, partnership, joint venture,
trust, or unincorporated organization, or a government or any agency or
political subdivision thereof.

         "Purchaser" and "Purchasers" shall have that meaning attributable to it
in Section 1.01 of this Agreement.

         "Qualified Public Offering" means a fully underwritten, firm commitment
public offering pursuant to an effective registration statement under the
Securities Act covering the offer and sale by the Company of any of its Class B
Common Stock in which the aggregate gross proceeds to the Company equal or
exceed $15,000,000.

         "Reserved Management Shares" means shares of Class B Common Stock, not
to exceed in the aggregate 4,500,000 shares (appropriately adjusted to reflect
stock splits, stock dividends, combinations of shares and the like with respect
to the Class B Common Stock) reserved by the Company for issuance pursuant to
stock purchase, stock grant or stock option arrangements for employees,
directors or consultants of the Company, all under arrangements approved by the
Board of Directors.

         "Securities Act" means the Securities Act of 1933, or any similar
Federal statute, and the rules and regulations of the Securities and Exchange
Commission (or of any other Federal agency then administering the Securities
Act) thereunder, all as the same shall be in effect at the time.

         "Series A Preferred" means the Series A Preferred Stock of the Company,
$.01 par value, having the rights, powers, privileges and preferences set forth
in EXHIBIT 1.01A.

         "Series B Preferred" means the Series B Participating Convertible
Preferred Stock of the Company, $.01 par value, having the rights, powers,
privileges and preferences set forth in EXHIBIT 1.01A hereto.

         "Series C Preferred" means the Series C Convertible Preferred Stock of
the Company, $.01 par value, having the rights, powers, privileges and
preferences set forth in EXHIBIT 1.01A hereto.

         "Series D Preferred" means the Series D Convertible Preferred Stock of
the Company, $.01 par value, having the rights, powers, privileges and
preferences set forth in EXHIBIT 1.01A hereto.

         "Shares" shall have that meaning attributable to it in Section 1.01 of
this Agreement.

         "Subsidiary" or "Subsidiaries" includes any corporation or trust of
which the Company and/or any of its other Subsidiaries (as herein defined)
directly or indirectly owns at the time at least fifty percent (50%) of the
outstanding shares of every class of such corporation or trust other than
directors' qualifying shares.

                                       30
<PAGE>

         6.02. ACCOUNTING TERMS. All accounting terms not specifically defined
herein shall be construed in accordance with GAAP.

                                   ARTICLE VII

                                  MISCELLANEOUS

         7.01. NO WAIVER; CUMULATIVE REMEDIES. No failure or delay on the part
of any party to this Agreement in exercising any right, power or remedy
hereunder shall operate as a waiver thereof; nor shall any single or partial
exercise of any such right, power or remedy preclude any other or further
exercise thereof or the exercise of any other right, power or remedy hereunder.
The remedies herein provided are cumulative and not exclusive of any remedies
provided by law.

         7.02. AMENDMENTS, WAIVERS AND CONSENTS. Any provision in this Agreement
to the contrary notwithstanding, and except as hereinafter provided, changes in
or additions to this Agreement may be made, and compliance with any covenant or
provision set forth herein may be omitted or waived, if the Company shall (i)
with respect to any provision other than those contained in Article IV or
Article V, obtain consent thereto in writing from the holder or holders of at
least 50% in interest of the Series D Preferred, and (ii) shall deliver copies
of such consent in writing to any holders who did not execute such consent. Any
waiver or consent may be given subject to satisfaction of conditions stated
therein and any waiver or consent shall be effective only in the specific
instance and for the specific purpose for which given. Notwithstanding anything
to the contrary contained herein, any waiver or amendment (A) which (x)
increases any Purchaser's obligations hereunder, (y) alters or amends the
percentage stated in Section 4.02 hereof, or (z) grants to any one or more
Purchasers any rights more favorable than any rights granted to all other
Purchasers or otherwise treats any one or more Purchasers differently than all
other Purchasers, must be approved by each Purchaser so as to be effective
against such Purchaser or (B) to Article IV or Article V (other than Section
5.07) must be approved by at least 50% in interest of the Series A Preferred,
Series B Preferred, Series C Preferred and Series D Preferred, voting together
as a single class. Notwithstanding anything to the contrary contained herein,
any waiver or amendment to Section 5.07 must be approved by at least 50% in
interest of the Series C Preferred. For purposes of the immediately preceding
sentence as it applies to Article IV or Article V, holders of Series A
Preferred, Series B Preferred and Series C Preferred shall be treated as
Purchasers; provided, that, the rights granted under Section 5.07 shall apply,
and are granted only to holders of Series C Preferred.

         7.03.    ADDRESSES FOR NOTICES.

                  (a) All notices, requests, demands and other communications
provided for hereunder shall be in writing and mailed, sent by facsimile
transmission or delivered to each applicable party at the address set forth in
EXHIBIT 1.01 hereto or at such other address as to which such party may inform
the other parties in writing in compliance with the terms of this Section.

         If to any other holder of the Shares: at such holder's address for
notice as set forth in the register maintained by the Company, or, as to each of
the foregoing, at the addresses set forth on

                                       31
<PAGE>

EXHIBIT 1.01 hereto or at such other address as shall be designated by such
Person in a written notice to the other parties complying as to delivery with
the terms of this Section.

         If to the Company: at 1881 Worcester Road, Suite 2, Framingham, MA
01701, or via facsimile at (508) 770-1596, Attention: Alex Seldin, Esq., or at
such other address as shall be designated by the Company in a written notice to
the other parties complying as to delivery with the terms of this Section; with
a copy to Hale and Dorr LLP, 60 State Street, Boston, MA 02109, or via facsimile
at (617) 526-5000, Attention: Leonard A. Pierce, Esq.

         If to any Purchaser associated with Amerindo Investment Advisors Inc.,
with a copy to Buchalter, Nemer, Fields & Younger, 601 South Figueroa Street,
Los Angeles, CA 90017 or via facsimile at (213) 896-0400, Attention: Rick Cohen,
Esq.

         If to any Purchaser associated with the @Ventures Purchasers, with a
copy to Hutchins, Wheeler & Dittmar, 101 Federal Street, Boston, MA 02110 or via
facsimile at (617) 951-1295, Attention: James Westra, Esq.

         If to any Purchaser associated with Munder Capital Management, with a
copy to Dechert, Price & Rhoads, 1775 Eye Street, NW,, Washington, DC 20006 or
via facsimile at (202) 261-3333, Attention: Jane A. Kanter.

         All such notices, requests, demands and other communications shall, (i)
when mailed (which mailing must be accomplished by express overnight courier
service or registered mail, return receipt requested), be effective two days
after deposited in the mails, (ii) when sent by facsimile, be effective one hour
after sending (or as of 8 a.m. Boston time on the following day, if faxed after
the later of 6 p.m. Boston time and the close of business of the recipient) and
(iii) when delivered by hand, upon receipt, in each case addressed as aforesaid,
unless otherwise provided herein.

         7.04. COSTS, EXPENSES AND TAXES. The Company, on the one hand, and the
Purchasers, on the other hand, shall each bear its own costs and expenses
(including accounting and legal fees and related expenses) incurred in
connection with the preparation, execution and delivery of this Agreement and
the transactions contemplated hereby; PROVIDED, HOWEVER, the Company agrees to
pay, upon receipt of proper documentation in reasonable detail, up to $25,000 of
the reasonable fees and out-of-pocket expenses of one legal counsel to the
Purchasers. In addition, the Company shall pay (i) any and all stamp and other
similar taxes payable or determined to be payable in connection with the
execution and delivery of this Agreement, the issuance of the Shares, and the
other instruments and documents to be delivered hereunder or thereunder, and
agrees to hold the Purchasers harmless from and against any and all liabilities
with respect to or resulting from any delay in paying or omission to pay such
taxes and (ii) upon receipt of proper documentation in reasonable detail, the
reasonable fees and out-of-pocket expenses of counsel to the Purchasers (not to
exceed $2,500 per transaction or $5,000 in the aggregate) incurred in connection
with reviewing any amendments, waivers, consents or approvals requested by the
Company in connection with this Agreement subsequent to the date hereof.

         7.05. BINDING EFFECT; ASSIGNMENT. This Agreement shall be binding upon
and inure to the benefit of the Company and the Purchasers and their respective
heirs, successors and assigns,

                                       32
<PAGE>

except that the Company shall not have the right to delegate any of its
respective obligations hereunder or to assign its respective rights hereunder or
any interest herein without the prior written consent of the holders of at least
60% in interest of the Series D Preferred.

         7.06. SURVIVAL. All representations and warranties made in this
Agreement, or any other instrument or document delivered in connection herewith
or therewith, and Section 7.13 shall survive the execution and delivery hereof
or thereof for a period of three years and Section 7.15 shall survive the
execution and delivery hereof or thereof without limitation.

         7.07. PRIOR AGREEMENTS. This Agreement constitutes the entire agreement
between the parties and, supersedes any prior understandings or agreements
concerning the purchase and sale of the Shares.

         7.08. SEVERABILITY. The provisions of this Agreement and the terms of
the Series D Preferred are severable and, in the event that any court of
competent jurisdiction shall determine that any one or more of the provisions or
part of a provision contained in this Agreement or the terms of the Series D
Preferred shall, for any reason, be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability shall not affect
any other provision or part of a provision of this Agreement or the terms of the
Series D Preferred; but this Agreement and the terms of the Series D Preferred
shall be reformed and construed as if such invalid or illegal or unenforceable
provision, or part of a provision, had never been contained herein, and such
provisions or part reformed so that it would be valid, legal and enforceable to
the maximum extent possible.

         7.09. GOVERNING LAW. This Agreement shall be construed and enforced in
accordance with and governed by the General Corporation Law of the State of
Delaware.

         7.10. HEADINGS. Article, Section and subsection headings in this
Agreement are included herein for convenience of reference only and shall not
constitute a part of this Agreement for any other purpose.

         7.11. COUNTERPARTS. This Agreement may be executed in any number of
counterparts, all of which taken together shall constitute one and the same
instrument, and any of the parties hereto may execute this Agreement by signing
any such counterpart.

         7.12. FURTHER ASSURANCES. From and after the date of this Agreement,
upon the request of any Purchaser or the Company, the Company and the Purchasers
shall execute and deliver such instruments, documents and other writings as may
be reasonably necessary or desirable to confirm and carry out and to effectuate
fully the intent and purposes of this Agreement and the Shares.

         7.13. INDEMNIFICATION. The Company shall, with respect to the
representations and warranties made by the Company herein, indemnify, defend and
hold the Purchasers harmless against all liability, loss or damage, together
with all reasonable costs and expenses related thereto (including legal and
accounting fees and expenses), arising from the untruth, inaccuracy or breach of
any such representations or warranties of the Company. Without limiting the
generality of the foregoing, the Purchasers shall be deemed to have suffered
liability, loss or damage (to the extent of their ownership interest in the
Company) as a result of the untruth,

                                       33
<PAGE>

inaccuracy or breach of any such representations or warranties if such
liability, loss or damage shall be suffered by the Company as a result of, or in
connection with, such untruth, inaccuracy or breach or any facts or
circumstances constituting such untruth, inaccuracy or breach. Each Purchaser
shall, severally and not jointly, with respect to the representations and
warranties made by such Purchaser herein, indemnify, defend and hold the Company
harmless against all liability, loss or damage, together with all reasonable
costs and expenses related thereto (including legal and accounting fees and
expenses), arising from the untruth, inaccuracy or breach of any such
representations or warranties of such Purchaser.

         7.14. AGGREGATION OF STOCK. All securities of the Company held or
acquired by an affiliate of any Purchaser or entities under common management
with or managed by such Purchaser shall be aggregated with those held or
acquired by such Purchaser for the purpose of determining the availability of or
discharge of any rights of such Purchaser under this Agreement.

         7.15 CONFIDENTIALITY. Each Purchaser shall, and shall cause its
affiliates (as the term is defined in the Securities Act) (individually, an
"Affiliate" and collectively "Affiliates") to, hold in confidence and shall use
its reasonable best efforts to cause all officers, directors and personnel who
continue after the Closing to be employed by the Purchaser or any Affiliate
thereof to hold in confidence all knowledge and information of a secret or
confidential nature with respect to the business of the Company and its
Affiliates and not to disclose, publish or make use of the same without the
consent of the Company, except to the extent that the information shall have
become public knowledge other than by breach of this Agreement by such
Purchaser, and provided that such Purchaser (i) may disclose information if
required by law upon prior written notice to the Company and (ii) may disclose
non-technical information regarding the Company's business and financial
performance which such Purchaser discloses generally to its partners and/or
shareholders. The Purchasers agree that the remedy at law for any breach of this
Section 7.15 would be inadequate and that the Company shall be entitled to
injunctive relief in addition to any other remedy it may have upon breach of any
provision of this Section 7.15.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                       34
<PAGE>

                               FURNITURE.COM, INC.

             SERIES D CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT

                           Counterpart Signature Page

         IN WITNESS WHEREOF, the undersigned has caused this Agreement to be
executed as of the date first above written.

                                    THE COMPANY:

                                    FURNITURE.COM, INC.,

                                    By:/s/ Andrew Brooks
                                       ------------------
                                    Name:  Andrew Brooks
                                    Title:   President/Chief Executive Officer

<PAGE>

                                                                   EXHIBIT 1.01

<TABLE>
<CAPTION>

                                                          SERIES D
                                                         CONVERTIBLE
               NAME AND ADDRESS                           PREFERRED                       PURCHASE
                 OF PURCHASERS                              STOCK                           PRICE
              -----------------                            -------                         ---------

<S>                                                     <C>                             <C>
Munder NetNet Fund                                      1,595,744.00                    14,999,993.60
480 Pierce Street, Ste. 300
Birmingham, MI 48009

@ Ventures III, L.P.                                      287,599.00                     2,703,430.60
100 Brickstone Square
Andover, MA 01810

Covestco-AtEura, LLC                                      265,957.00                     2,499,995.80
c/o Jura Trust
Mitteldorf 1
Vedez, Lichtenstein, FL-9490
Attention: Albin A. Johann

Arkaro Holding B.V.                                       244,949.00                     2,302,520.60
Locatellikade 1
1076 AZ Amsterdam
The Netherlands

Comdisco, Inc.                                            106,383.00                     1,000,000.20
6111 North River Road
Rosemont, IL 60018
ATTN: Venture Group

Litton Master Trust                                       106,383.00                     1,000,000.20
c/o Amerindo Investment Advisors Inc.
399 Park Avenue, 22nd Floor
New York, NY 10022

CMG @Ventures III, LLC                                     95,266.00                      895,500.40
100 Brickstone Square
Andover, MA 01810

@ Ventures Foreign Fund                                    86,284.00                      811,069.60
100 Brickstone Square
Andover, MA 01810
</TABLE>

<PAGE>

<TABLE>

<S>                                                        <C>                            <C>
Bessemer Venture Partners IV, L.P.                         63,830.00                      600,002.00
c/o Bessemer Venture Partners
1400 Old Country Road, Suite 407
Westbury, NY 11590

RRE Investors LP                                           51,457.00                     483,695.80
126 E. 56th Street
New York, NY 10022

Bessec Ventures IV L.P.                                    42,553.00                     399,998.20
c/o Bessemer Venture Partners
1400 Old Country Road, Suite 407
Westbury, NY 11590

Trellus Partners, LP                                       36,450.00                     342,630.00
152 West 57th Street, 57th Floor
New York, NY 10019

RRE Investors Fund LP                                      28,330                        266,302.00
126 E. 56th Street
New York, NY 10022

Mitchell P. Bartlett                                       10,000.00                      94,000.00
28 Gale Road
Woodland, MN 55391

Robert Reynolds                                            10,000.00                      94,000.00
74 Greenwood Way
Mill Valley, CA 94941

@ Ventures Investors, LLC                                   9,574.00                      89,995.60
100 Brickstone Square
Andover, MA 01810                                       -------------------       -------------------

Totals:                                                 3,040,759.00                  28,583,134.60
</TABLE>

<PAGE>

                                                                  EXHIBIT 1.01A

                            PURCHASER SIGNATURE PAGE

         By its execution and delivery of this signature page, the undersigned
Purchaser of Series D Convertible Preferred Stock hereby joins in and agrees to
be bound by the terms and conditions of (i) the Series D Convertible Preferred
Stock Purchase Agreement dated as of December 30, 1999 by and among
Furniture.com, Inc. (the "Company") and the Purchasers (as defined therein), as
to the number of shares of Series D Convertible Preferred Stock set forth below,
(ii) the Third Amended and Restated Registration Rights Agreement dated as of
December 30, 1999, between the Company and certain stockholders of the Company
(the "Registration Rights Agreement"), as an Investor as such term is defined
therein, and (iii) the Third Amended and Restated Stockholders' Agreement dated
as of December 30, 1999 between the Company and the stockholders of the Company
(the "Stockholders' Agreement"), as an Investor as such term is defined therein,
and authorizes this Purchaser Signature Page to be attached to the Series D
Convertible Preferred Stock Purchase Agreement, the Registration Rights
Agreement, and the Stockholders' Agreement or counterparts thereof.

                                            Name of Purchaser

                                            -----------------------------------

                                            By: /s/ [Multiple Signers]
                                              ---------------------------------
                                              Title:

                                            Record
                                            Address:
                                                    ---------------------------

                                            ------------------------------------

                                             Telecopy No.:
                                                         ----------------------

                                             Number of Shares of
                                             Series D Convertible
                                             Preferred Stock:
                                                             ------------------

Agreed to and accepted this
30th day of December, 1999

FURNITURE.COM, INC.

By: /s/ Alex Seldin
    -------------------------
    Title: VP, Legal & Business Affairs<PAGE>

                                                                 Exhibit 10.9

                           THIRD AMENDED AND RESTATED
                             STOCKHOLDERS' AGREEMENT

         THIRD AMENDED AND RESTATED STOCKHOLDERS' AGREEMENT made this 30th day
of December, 1999, by and among (i) Furniture.com, Inc., a Delaware corporation
(the "Company"), (ii) Steven Rothschild and Misha Katz (the "Founders"), (iii)
each person who shall, after the date hereof, acquire or receive the right to
acquire or hold shares of Class B Common Stock (as defined below) and join in
and become a party to this Agreement by executing and delivering to the Company
an Instrument of Accession in the form of SCHEDULE II hereto (the "Non-Founder
Stockholders") (the Founders and the Non-Founder Stockholders are referred to as
the "Holders"), and (iv) those persons whose names are set forth under the
heading "Investors" on SCHEDULE I hereto, as amended from time to time (the
"Investors"); PROVIDED HOWEVER, that notwithstanding the foregoing, Michael
Barach shall be considered (i) a "Non-Founder Stockholder" for purposes of
defining rights and restrictions described herein in connection with any shares
of the Company's Class B Common Stock, $.01 par value per share (the "Class B
Common Stock") other than Conversion Shares (as defined below), held by him or
his permitted transferees and (ii) a "Series A Investor" (as defined below) for
purposes of defining rights and restrictions described herein in connection with
any shares of the Company's Series A Preferred Stock, $.01 par value per share
(the "Series A Preferred Stock"), or the Company's Class A Common Stock, $.01
par value per share (the "Class A Common Stock") or the Conversion Shares, held
by him or his permitted transferees.

         WHEREAS, the Holders currently hold collectively 6,043,974 shares of
the Class B Common Stock;

         WHEREAS, certain Investors (the "Series A Investors") currently hold an
aggregate of 3,009,600 shares of the Series A Preferred Stock and an aggregate
of 3,040,000 shares of the Class A Common Stock;

         WHEREAS, certain Investors (the "Series B Investors") currently hold an
aggregate of 7,042,254 shares of the Company's Series B Preferred Stock, par
value $.01 per share (the "Series B Preferred Stock");

         WHEREAS, certain Investors (the "Series C Investors") currently hold an
aggregate of 4,727,786 shares of the Company's Series C Preferred Stock, par
value $.01 per share (the "Series B Preferred Stock");

         WHEREAS, the Founders, Non-Founder Stockholders, Series A Investors,
the Series B Investors, the Series C Investors and the Company are parties to a
Second Amended and Restated Stockholders' Agreement dated June 23, 1999 (the
"Original Agreement; and

         WHEREAS, certain Investors (the "Series D Investors") are acquiring
simultaneously herewith up to an aggregate of 3,200,000 shares of the Company's
Series D Preferred Stock, par value $.01 per share (the "Series D Preferred
Stock"), pursuant to a Series D Convertible Preferred Stock Purchase Agreement,
dated as of the date hereof (the "Purchase Agreement"), by and among the Company
and the Series D Investors;

<PAGE>

         WHEREAS, the term "Investor Shares", as used herein, shall mean shares
of (i) the Series A Preferred Stock, (ii) the Series B Preferred Stock, (iii)
the Series C Preferred Stock, (iv) the Series D Preferred Stock, (v) the Class A
Common Stock, and (vi) the Class B Common Stock issued or issuable upon
conversion of the Class A Common Stock, upon conversion of the Series B
Preferred Stock, upon conversion of the Series C Preferred Stock and upon
conversion of the Series D Preferred Stock, in each case whether now or
hereafter acquired; and

         WHEREAS, the term "Conversion Shares", as used herein, shall mean the
Class B Common Stock issued or issuable upon conversion of the Class A Common
Stock, upon conversion of the Series B Preferred Stock, upon conversion of the
Series C Preferred Stock and upon conversion of the Series D Preferred Stock, in
each case whether now or hereafter acquired.

         NOW, THEREFORE, in consideration of the mutual covenants herein
contained and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company, the Holders and the Investors
agree that the Original Agreement be, and hereby is, amended and restated in its
entirety as follows:

         1. PROHIBITED TRANSFERS. The Holders shall not sell, assign, transfer,
pledge, hypothecate, mortgage or dispose of, by gift or otherwise, or in any way
encumber, all or any part of the Shares (as hereinafter defined) owned by them
except in compliance with the terms of this Agreement. For purposes of this
Agreement, the term "Shares" shall mean and include all shares of equity
securities of the Company owned by the Holders, whether presently held or
hereafter acquired.

         2. RIGHT OF REFUSAL ON DISPOSITIONS BY THE FOUNDERS.

         (a) If at any time any Founder wishes to sell, assign, transfer or
         otherwise dispose of any or all Shares owned by such Founder pursuant
         to the terms of a bona fide offer received from a third party, such
         Founder shall submit a written offer to sell such Shares to the Company
         on terms and conditions, including price, not less favorable to the
         Company than those on which such Founder proposes to sell such Shares
         to such third party (the "Offer"). The Offer shall disclose the
         identity of the proposed purchaser or transferee, the Shares proposed
         to be sold or transferred, the agreed terms of the sale or transfer and
         any other material facts relating to the sale or transfer. Within ten
         (10) days after receipt of the Offer, the Company shall give notice to
         such Founder of its intent to purchase all or any portion of the
         offered Shares on the same terms and conditions as set forth in the
         Offer.

                  (b) If, for any reason whatever, the Company shall not
exercise its right to purchase all of the offered Shares as provided herein,
then each of the Investors shall have the right to purchase a portion of the
offered Shares which the Company shall not have agreed to purchase from such
Founder (all such remaining shares being referred to as the "Remaining Offered
Shares") to be determined in the manner set forth herein.

                  (c) Each Investor shall have the right to purchase that number
of the Remaining Offered Shares as shall be equal to the aggregate Remaining
Offered Shares multiplied by a fraction, the numerator of which is the number of
Conversion Shares then held or

                                      -2-
<PAGE>

deemed to be held by such Investor and the denominator of which is the aggregate
number of Conversion Shares then held or deemed to be held by all the Investors.
(The amount of shares each Investor or Qualified Transferee, as that term is
defined below, is entitled to purchase under this Section 2 shall be referred to
as his "Pro Rata Fraction"). Each Investor shall have the right to accept the
Offer as to all or part of the Remaining Offered Shares offered thereby. Each
Investor shall have the right to transfer his right to purchase any Pro Rata
Fraction or part thereof to any Qualified Transferee. To the extent an Investor
(together with its Qualified Transferees) does not elect to purchase all of its
Pro Rata Fraction, then any Investor who does elect to purchase all or part of
its Pro Rata Fraction shall have the right to purchase, on a pro rata basis with
any other Investor who so elects, to purchase the portion of the non-electing
Investor's Pro Rata Fraction not purchased by such Investor or its Qualified
Transferees.

                  (d) Each Investor shall act upon the Offer as soon as
practicable after receipt from the Company of notice that the Company has not
elected to purchase all of the offered Shares, and in all events within five (5)
days after receipt thereof. In the event that an Investor shall elect to
purchase all or part of the Remaining Offered Shares covered by the Offer, said
Investor shall individually communicate in writing such election to purchase to
the Founder who has made the Offer, which communication shall be delivered by
hand or mailed to such Founder at the address set forth in Section 9 below and
shall, when taken in conjunction with the Offer be deemed to constitute a valid,
legally binding and enforceable agreement for the sale and purchase of the
Shares covered thereby.

                  (e) In the event that the Company and the Investors, taken
together and their Qualified Transferees, do not purchase all of the Shares
offered by such Founder pursuant to and within thirty (30) days after the Offer,
any Shares not purchased may be sold by such Founder at any time within 120 days
after the expiration of the Offer, but subject to the provisions of Section 4
below. Any such sale shall be at not less than the price and upon other terms
and conditions, if any, not more favorable to the purchaser than those specified
in the Offer. Any Shares not sold within such 120-day period shall continue to
be subject to the requirements of a prior offer and re-sale pursuant to this
Section. In the event that Shares are sold to any purchaser pursuant to this
Section 2, said Shares shall no longer be entitled to the benefits conferred by,
or subject to the restrictions imposed by, this Agreement, except that the
purchaser of said Shares shall agree in writing to abide by the provisions of
Section 7 hereof.

                  (f) For purposes of this Agreement, a "Qualified Transferee"
shall mean any person who (i) is an Investor, (ii) is an affiliate (as defined
in the Investment Company Act of 1940) of an Investor, (iii) is a partner of an
Investor, (iv) is the transferee of a transfer described in Section 6, or (v) is
the transferee of a gift of Investor Shares made by an Investor no more than
once during any twelve-month period.

         3. RIGHT OF REFUSAL ON DISPOSITIONS BY THE NON-FOUNDER STOCKHOLDERS.

         (a) If at any time any of the Non-Founder Stockholders wishes to sell,
         assign, transfer or otherwise dispose of any or all Shares owned by him
         pursuant to the terms of a bona fide offer received from a third party,
         he shall submit a written offer to sell such Shares to the Company on
         terms and conditions, including price, not less favorable to the
         Company than those on which he proposes to sell such Shares to such
         third party (the "Stockholder

                                      -3-
<PAGE>

         Offer"). The Stockholder Offer shall disclose the identity of the
         proposed purchaser or transferee, the Shares proposed to be sold or
         transferred, the agreed terms of the sale or transfer and any other
         material facts relating to the sale or transfer. Within ten (10) days
         after receipt of the Stockholder Offer, the Company shall give notice
         to the Non-Founder Stockholder of its intent to purchase all or any
         portion of the offered Shares on the same terms and conditions as set
         forth in the Stockholder Offer.

                  (b) If, for any reason whatever, the Company shall not
exercise its right to purchase all of the offered Shares as provided herein,
then each of the Investors and the Founders shall have the right to purchase a
portion of the offered Shares which the Company shall not have agreed to
purchase from the Non-Founder Stockholder (all such remaining shares being
referred to as the "Stockholder Remaining Offered Shares") to be determined in
the manner set forth herein.

                  (c) Each Investor shall have the right to purchase that number
of the Stockholder Remaining Offered Shares as shall be equal to the aggregate
Stockholder Remaining Offered Shares multiplied by a fraction, the numerator of
which is the number of Conversion Shares then held or deemed to be held by such
Investor and the denominator of which is the sum of (i) the aggregate number of
Conversion Shares then held or deemed to be held by all the Investors and (ii)
the aggregate number of Shares held or deemed to be held by all of the Founders.
Each Founder shall have the right to purchase that number of the Stockholder
Remaining Offered Shares as shall be equal to the aggregate Stockholder
Remaining Offered Shares multiplied by a fraction, the numerator of which is the
number of Shares then held or deemed to be held by such Founder and the
denominator of which is the sum of (i) and (ii) above. (The amount of shares
each Investor, Founder or Qualified Transferee is entitled to purchase under
this Section 3 shall be referred to as his "Stockholder Pro Rata Fraction").
Each Investor or Founder, as the case may be, shall have the right to accept the
Stockholder Offer as to all or part of the Stockholder Remaining Offered Shares
offered thereby. Each Investor and Founder shall have the right to transfer his
right to purchase any Stockholder Pro Rata Fraction or part thereof to any
Qualified Transferee. To the extent an Investor or Founder (together with its
Qualified Transferees) does not elect to purchase all of its right to purchase
its Stockholder Pro Rata Fraction, then any Investor or Founder who does elect
to purchase all or part of its Stockholder Pro Rata Fraction shall have the
right to purchase, on a pro rata basis with any other Investor or Founder who so
elects, to purchase the portion of the non-electing Investor's or Founder's
Stockholder Pro Rata Fraction not purchased by such Investor, Founders or their
Qualified Transferees.

                  (d) Each Investor or Founder, as the case may be, shall act
upon the Stockholder Offer as soon as practicable after receipt from the Company
of notice that the Company has not elected to purchase all of the offered
Shares, and in all events within five (5) days after receipt thereof. In the
event that an Investor or Founder shall elect to purchase all or part of the
Stockholder Remaining Offered Shares covered by the Stockholder Offer, said
Investor or Founder shall individually communicate in writing such election to
purchase to whichever Non-Founder Stockholder has made the Stockholder Offer,
which communication shall be delivered by hand or mailed to such Non-Founder
Stockholder at the address set forth in Section 9 below and shall, when taken in
conjunction with the Stockholder Offer be deemed to

                                      -4-
<PAGE>

constitute a valid, legally binding and enforceable agreement for the sale and
purchase of the Shares covered thereby.

                  (e) In the event that the Company, the Investors, the
Founders, and their respective Qualified Transferees, taken together, do not
purchase all of the Shares offered by a Non-Founder Stockholder pursuant to and
within thirty (30) days after the Stockholder Offer, any Shares not purchased
may be sold by such Non-Founder Stockholder at any time within 120 days after
the expiration of the Stockholder Offer. Any such sale shall be at not less than
the price and upon other terms and conditions, if any, not more favorable to the
purchaser than those specified in the Stockholder Offer. Any Shares not sold
within such 120-day period shall continue to be subject to the requirements of a
prior offer and re-sale pursuant to this Section. In the event that Shares are
sold to any purchaser pursuant to this Section, said Shares shall no longer be
entitled to the benefits conferred by, or subject to the restrictions imposed
by, this Agreement, except that the purchaser of said Shares shall agree in
writing to abide by the provisions of Section 7 hereof.

         4. RIGHT OF PARTICIPATION IN SALES. If at any time any Founder wishes
to sell, or otherwise dispose of any Shares owned by such Founder to any person
(the "Purchaser") in a transaction which is subject to the provisions of Section
2 hereof, each Investor shall have the right to require, as a condition to such
sale or disposition, that the Purchaser purchase from said Investor at the same
price per share and on the same terms and conditions as involved in such sale or
disposition by such Founder the same percentage of Conversion Shares owned and
deemed to be owned hereunder by such Investor as such sale or disposition (as
finally consummated) represents with respect to said Shares then owned by such
Founder. Each Investor wishing so to participate in any such sale or disposition
shall notify such Founder of such intention as soon as practicable after receipt
of the Offer made pursuant to Section 2, and in all events within fifteen (15)
days after receipt thereof. In the event that an Investor shall elect to
participate in such sale or disposition, said Investor shall individually
communicate such election to such Founder, which communication shall be
delivered by hand or mailed to such Founder at the address set forth in Section
9 below. Such Founder and/or each participating Investor shall sell to the
Purchaser all, or at the option of the Purchaser, any part of the Shares and
Conversion Shares (as the case may be) proposed to be sold by them at not less
than the price and upon other terms and conditions, if any, not more favorable
to the Purchaser than those originally offered; PROVIDED, HOWEVER, that any
purchase of less than all of such Shares and Conversion Shares (as the case may
be) by the Purchaser shall be made from such Founder and/or each participating
Investor based upon a fraction, the numerator of which is the number of Shares
or Conversion Shares (as the case may be) of the Company then owned by such
Founder or such participating Investor and the denominator of which is the
aggregate number of Shares and Conversion Shares held by and deemed to be held
by such Founder and all of the participating Investors. Such Founder shall use
his or her best efforts to obtain the agreement of the Purchaser to the
participation of the participating Investors in the contemplated sale, and shall
not sell any Shares to such Purchaser if such Purchaser declines to permit the
participating Investors to participate pursuant to the terms of this Section 4.
The provisions of this Section 4 shall not apply to the sale of any Shares by a
Founder to an Investor pursuant to an Offer under Section 2.

         5. TAKE ALONG RIGHT. If an Investor or group of Investors holding more
than 67% of the Conversion Shares held by all Investors and subject to this
Agreement (the "Take Along

                                      -5-
<PAGE>

Group") determine to sell or exchange in one or a series of related bona fide
arms-length transactions to a third party or third parties (collectively, the
"Third Party"), 67% or more of the aggregate number of Conversion Shares subject
to this Agreement (the "Take Along Shares"), such Take Along Group shall give
not less than fifteen (15) days prior written notice of such intended transfer
(the "Transfer") to each other Investor and the Holders, which notice shall
include reasonable details of the proposed sale or exchange including the
proposed time and place of closing, the consideration to be received by the Take
Along Group and any other material terms of such transfer (such notice being
referred to as a "Sale Notice"). Each of such Investors and the Holders shall,
if specified in such Sale Notice, be obligated to, and shall, sell, transfer and
deliver, or cause to be sold, transferred and delivered, to such Third Party on
the same financial terms as the Take Along Group, that number of Shares owned by
such Investor or Holder as shall equal the product of (w) a fraction, the
numerator of which is the number of Conversion Shares proposed to be transferred
by the Take Along Group as of the date of such Sale Notice and the denominator
of which is the aggregate number of Conversion Shares held or deemed to be held
as of the date of such Sale Notice by the Take Along Group, multiplied by (x)
the number of Shares actually owned as of the date of such Sale Notice by such
Investor or Holder. Each such Investor and the Holders shall, if specified in
such Sale Notice, be obligated to, and shall, sell, transfer and deliver, or
cause to be sold, transferred and delivered, to such Third Party on the same
financial terms as the Take Along Group, that number of Conversion Shares held
or deemed to be held by such Investor and the Holders as shall equal the product
of (y) a fraction, the numerator of which is the number of Conversion Shares
proposed to be transferred by the Take Along Group as of the date of such Sale
Notice and the denominator of which is the aggregate number of Conversion Shares
held or deemed to be held as of the date of such Sale Notice by the Take Along
Group, multiplied by (z) the number of Conversion Shares held or deemed to be
held as of the date of such Sale Notice by such Investor or Holder. Each Holder
or Investor, if required to sell pursuant to this Section 5, shall (A) deliver
certificates evidencing the applicable Shares or Conversion Shares to be sold at
the closing of the proposed Transfer, duly endorsed or accompanied by duly
executed stock powers, free and clear of all liens, claims, charges, security
interests and other encumbrances of any nature whatsoever, and shall receive in
exchange therefor the consideration to be paid or delivered by such Third Party
in respect of such Shares or Conversion Shares as described in the Sale Notice
(which consideration per share shall be the same for all of the Take Along
Group, the Holders and the Investors) and (B) if stockholder approval for the
transaction is required, vote such Shares or Conversion Shares in favor thereof.

         6. PERMITTED TRANSFERS. Anything herein to the contrary
notwithstanding, the provisions of Sections 1, 2, 3, 4 and 5 shall not apply
to: (a) any transfer of Shares to one or more of its partners or members in
any Holder or Investor that is a partnership or limited liability company or
to a retired or withdrawn partner or member who retires or withdraws after
the date hereof in full or partial distribution of his interest in such
partnership or limited liability company; (b) any transfer of Shares to any
immediate family member (which shall be deemed to include a spouse, sibling,
lineal descendant, ancestor, mother-in-law, father-in-law, brother-in-law and
sister-in-law) of an individual Holder or Investor by gift or bequest or
through inheritance, or to a trust or family limited partnership (or other
similar entity) created for the benefit of one or more of the foregoing; (c)
any transfer of Shares to any shareholder of any Holder or Investor that is a
corporation; (d) any transfer of Shares to any person or entity acquiring at
least 250,000 shares of Shares (such number being subject to adjustment for
any

                                      -6-
<PAGE>

stock dividend, stock split, subdivision, combination or other
recapitalization); (e) any sale of the Company's equity securities in a
public offering pursuant to a registration statement filed by the Company
with the Securities and Exchange Commission (the "Commission"); and (f) any
sale permitted pursuant to Section 1.05 of the Purchase Agreement. In the
event of any such transfer, other than pursuant to subsection (e) of this
Section 6, the transferee of the Shares shall agree to become a party to this
Agreement and shall hold the Shares so acquired with all the rights conferred
by, and subject to all the restrictions imposed by, this Agreement.
Notwithstanding anything herein to the contrary, in no event may any Holder
or Investor, together with its affiliates and assigns, assign their rights
and obligations hereunder to more than 10 persons in the aggregate.

         7. ELECTION OF DIRECTORS. Each of the parties entitled to vote hereto
agrees to vote all of the Stock (as hereinafter defined) of the Company now
owned or hereafter acquired by such party (and attend, in person or by proxy,
all meetings of stockholders called for the purpose of electing directors), and
the Company agrees to take all actions (including, but not limited to the
nomination of specified persons) to cause and maintain the election to the Board
of Directors of the Company, to the extent permitted pursuant to the Company's
Certificate of Incorporation, the following:

                  (i) as long as shares of Series A Preferred Stock are
outstanding, one nominee designated by Brand Equity Ventures I, L.P., who shall
initially be Christopher P. Kirchen;

                  (ii) as long as shares of Series A Preferred Stock are
outstanding, one nominee designated by 60% in interest of the holders of Series
A Preferred Stock, who shall initially be Michael Barach, and if no shares of
Series A Preferred Stock are outstanding, one nominee designated by 60% in
interest of the holders of the Class B Common Stock issuable upon conversion of
the Class A Common Stock, whether now owned or hereafter acquired (the "Series A
Conversion Shares");

                  (iii) two nominees designated by a majority in interest of the
holders of the Class B Common Stock, one of whom shall initially be Steven
Rothschild, who shall initially serve as Chairman, and the other shall initially
be Jason Olim; and

                  (iv) as long as shares of Series A Preferred Stock are
outstanding, one nominee to be designated by a majority in interest of the
holders of Series A Preferred Stock, who shall initially be Andrew Brooks, and
if no shares of Series A Preferred Stock are outstanding, by 60% in interest of
the holders of Series A Conversion Shares, and approved by a majority in
interest of the holders of the Class B Common Stock;

                  (v) as long as shares of Series B Preferred Stock (or shares
of Class B Common Stock issuable upon conversion of the Series B Preferred
Stock, whether now owned or hereafter acquired ("Series B Conversion Shares"))
are outstanding, one nominee designated by @Ventures III, L.P., who shall
initially be Marc Poirier;

                  (vi) as long as shares of Series B Preferred Stock are
outstanding, one nominee designated by 60% in interest of the holders of Series
B Preferred Stock, and if no shares of

                                      -7-
<PAGE>

Series B Preferred Stock are outstanding, one nominee designated by 60% in
interest of the holders of the Series B Conversion Shares, who shall initially
be Joanna Strober; and

                  (vii) as long as shares of Series C Preferred Stock and/or
Series D Preferred Stock are outstanding, one nominee designated by the holders
of shares representing at least 60% of the votes represented by the shares of
Series C Preferred Stock and Series D Preferred Stock then outstanding, and if
no shares of Series C Preferred Stock or Series D Preferred Stock are
outstanding, one nominee designated by 60% in interest of the holders of Class B
Common Stock issuable upon conversion of the Series C Preferred Stock and Series
D Preferred Stock, whether now owned or hereafter acquired, in each case the
nominee shall not be a Series C Investor or a Series D Investor or an affiliate
thereof; such nominee shall initially be undesignated.

                  Each of the parties further covenants and agrees to vote, to
the extent possible, all shares of Stock of the Company now owned or hereafter
acquired by such party so that the Company's Board of Directors shall consist of
eight (8) members.

                  For the purposes of this Agreement, "Stock" shall mean and
include all Series A Preferred Stock, Series B Preferred Stock, Series C
Preferred Stock, Series D Preferred Stock, Class A Common Stock, Class B Common
Stock (including shares of Class B Common Stock issued upon conversion of other
securities), and all other securities of the Company which may be exchangeable
for or issued in exchange for or in respect of shares of Series A Preferred
Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred
Stock, Class A Common Stock or Class B Common Stock (whether by way of stock
split, stock dividends, combination, reclassification, reorganization or any
other means) whether now held or hereafter acquired.

                  In the absence of any designation from the persons or groups
so designating directors as specified above, the director previously designated
by them and then serving shall be reelected if still eligible to serve as
provided herein.

                  Except in the case of bad faith or willful misconduct by a
member of the Board of Directors, no party hereto shall vote to remove any
member of the Board of Directors designated in accordance with the aforesaid
procedures unless the persons or groups so designating directors as specified
above so vote, and, if such persons or groups so vote then the non-designating
party or parties shall likewise so vote.

                  Any vacancy on the Board of Directors created by the
resignation, removal, incapacity or death of any person designated under this
Section 7 shall be filled by another person designated in a manner so as to
preserve the constituency of the Board as provided above. If a person is not so
designated, such vacancy shall be filled by a person elected by the vote of a
majority of the holders of Stock, voting together as a class.

         8. TERMINATION. This Agreement, and the respective rights and
obligations of the parties hereto, shall terminate UPON the earliest to occur of
the following: (i) the completion of a fully underwritten, firm commitment
public offering pursuant to an effective registration statement under the
Securities Act of 1933 covering the Offering or sale by the Company of its
equity securities in which the aggregate gross proceeds received by the Company
shall be at least

                                      -8-
<PAGE>

$15 million; (ii) the sale of the Company, whether by merger, sale, or transfer
of capital stock representing a majority of the voting power at elections of
directors of the Company, or sale of substantially all of its assets or (iii)
upon the Company becoming a reporting person under Section 12 of the Securities
Exchange Act of 1934.

         9. NOTICES. All notices, requests, demands and other communications
provided for hereunder shall be in writing and mailed, sent by facsimile
transmission or delivered to each applicable party at the address set forth on
SCHEDULE I hereto or on the Instrument of Accession pursuant to which he became
a party to this Agreement or at such other address as to which such party may
inform the other parties in writing in compliance with the terms of this
Section.

         If to the Company: at 1881 Worcester Road, Suite 2, Framingham, MA
01701, or via facsimile at (508) 770-1596, Attention: Andrew Brooks, or at such
other address as shall be designated by the Company in a written notice to the
OTHER parties complying as to delivery with the terms of this Section; with a
copy to Hale and Dorr LLP, 60 State Street, Boston, MA 02109, or via facsimile
at (617) 526-5000, Attention: Leonard A. Pierce, Esq.

         If (i) to any holder of Series C Preferred Stock associated with
Amerindo Investment Advisors Inc., with a copy to Buchalter, Nemer, Fields &
Younger, 601 South Figueroa Street, Los Angeles, CA 90017 or via facsimile at
(213) 896-0400, Attention: Rick Cohen, Esq. and (ii) to any party associated
with the @Ventures Purchasers (as defined in the Purchase Agreement), with a
copy to Hutchins, Wheeler & Dittmar, 101 Federal Street, Boston, MA 02110 or via
facsimile at (617) 951-1295, Attention: James Westra, Esq.

         All such notices, requests, demands and other communications shall, (i)
when mailed (which mailing must be accomplisheD by express overnight courier
service or registered mail, return receipt requested), be effective two DAYS
after deposited in the mails, (ii) when sent by facsimile, be effective one hour
after sending (or as of 8 a.m. Boston time on the following day, if faxed after
the later of 6 p.m. Boston time and the close of business of the recipient) and
(iii) when delivered by hand, upon receipt, in each case addressed as aforesaid,
unless otherwise provided herein.

                                      -9-
<PAGE>

         10. LOCK-UP AGREEMENT. If requested in writing by the underwriters for
the initial underwritten public offering of securities of the Company, each
Holder and Investor shall agree not to sell publicly any shares of Stock without
the consent of such underwriters, for a period of not more than 180 days
following the date APPEARING on the final prospectus relating to such offering;
PROVIDED, HOWEVER, that all persons entitled to registration rights with respect
to shares of Stock and who are not parties to this Agreement, all executive
officers, directors and 1% shareholders of the Company shall also have agreed
not to sell publicly their Stock under the circumstances and pursuant to the
terms set forth herein; PROVIDED, FURTHER, that the restrictions contained in
this Section 10 shall not apply to any securities acquired by the Series C
Investors in the Company's first Qualified Public Offering (as defined in the
Purchase Agreement) (other than securities acquired pursuant to Section 5.07 of
the Purchase Agreement which may be subject to such restrictions to the extent
necessary to comply with applicable law and rules and regulations of the
Commission and the National Association of Securities Dealers, Inc.) or to
securities acquired by the Series C Investors on the open market after the
Company's first Qualified Public Offering.

         11. SPECIFIC PERFORMANCE. The rights of the parties under this
Agreement are unique and, accordingly, the parties shall, in addition to such
other remedies as MAY be available to any of them at law or in equity, have the
right to enforce their rights hereunder by actions for specific performance to
the extent permitted by law.

         12. LEGEND. The certificates representing the Stock shall bear on their
face a legend indicating the existence of the restrictions imposed hereby.

         13. ENTIRE AGREEMENT. This Agreement, the Purchase Agreement (including
any and all Exhibits, Schedules and other instruments contemplated thereby) and
the Third Amended and Restated Registration Rights Agreement dated the date
hereof among the Company and certain of its stockholders named therein
constitute the entire agreement among the parties with respect to the subject
matter hereof and supersede all prior agreements and understandings between them
or any of them as to such subject matter.

         14. WAIVERS AND FURTHER AGREEMENTS. Any of the provisions of this
Agreement for the benefit of the Series A Investors may be waived with the
consent of the Series A Investors holding at least 60% in interest of the Series
A Conversion Shares then held or deemed to be held by all Series A Investors.
Any of the provisions of this Agreement for the benefit of the Series B
Investors may be waived with the consent of the Series B Investors holding at
least 60% in interest of the Series B Conversion Shares then held or deemed to
be held by all Series B Investors and, in the case of any waiver of the benefits
of paragraph (v) of Section 7 hereof, with the consent of @Ventures III, L.P.
Any of the provisions of this Agreement for the benefit of the Series C
Investors may be waived with the consent of the Series C Investors holding at
least 60% in interest of the Series C Conversion Shares then held or deemed to
be held by all Series C Investors. Any of the provisions of this Agreement for
the benefit of the Series D Investors may be waived with the consent of the
Series D Investors holding at least 60% in interest of the Series D Conversion
Shares then held or deemed to be held by all Series D Investors. Any waiver by
any party of a breach of any provision of this Agreement shall not operate or be
construed as a waiver of any subsequent breach of that provision or of any other
provision hereof. Each of the parties hereto agrees to execute all such further
instruments and documents

                                      -10-
<PAGE>

and to take all such further action as any other party may reasonably require in
order to effectuate the terms and purposes of this Agreement. Notwithstanding
the foregoing, no waiver approved in accordance herewith shall be effective if
and to the extent that such waiver (i) grants to any one or more Investors any
rights more favorable than any rights granted to all other similarly situated
Investors or otherwise treats any one or more Investors differently than all
other similarly situated Investors and (ii) waives any of the rights of the
Founders without the additional written consent of the Founders.

         15. AMENDMENTS. Except as otherwise expressly provided herein, this
Agreement may not be amended except by an instrument in writing executed by (i)
Series A Investors holding at least 60% in interest of the Series A Conversion
Shares then held or deemed to be held by all Series A Investors, (ii) Series B
Investors holding at least 60% in interest of the Series B Conversion Shares
then held or deemed to be held by all Series B Investors, (iii) Series C
Investors holding at least 60% in interest of the Series C Conversion Shares
then held or deemed to be held by all Series C Investors, (iv) Series D
Investors holding at least 60% in interest of the Series D Conversion Shares
then held or deemed to be held by all Series D Investors and (v) Holders (not
including Investors) holding a majority of the Shares subject to this Agreement.
Notwithstanding the foregoing, no amendment approved in accordance with clauses
(i), (ii), (iii), (iv) and (v) above shall be effective if and to the extent
that such amendment: (a) creates any additional affirmative obligations to be
complied with by any or all of the Investors or Holders, (b) grants to any one
or more Investors or Holders any rights more favorable than any rights granted
to all similarly situated Investors or Holders, as the case may be, or (c)
otherwise treats any one or more Investors or Holders differently than all other
similarly situated Investors or Holders. In addition, Section 7 of this
Agreement shall not be amended with (i) regard to Brand Equity Ventures I,
L.P.'s right to designate a representative to the Board of Directors without the
written consent of Brand Equity Ventures I, L.P. or (ii) with regard to
@Ventures III, L.P.'s right to designate a representation to the Board of
Directors without the written consent of @Ventures III, L.P.

         16. ASSIGNMENT; SUCCESSORS AND ASSIGNS. This Agreement shall be binding
upon and shall inure to the benefit of the parties hereto and their respective
heirs, executors, legal representatives, successors and Qualified Transferees,
except as may be expressly provided otherwise herein, AND PROVIDED, FURTHER,
that no Investor may transfer its rights or obligations hereunder except to a
Qualified Transferee.

         17. SEVERABILITY. In case any one or more of the provisions contained
in this Agreement shall for any reason be held to be INVALID, illegal or
unenforceable in any respect, such invalidity, illegality or unenforceability
shall not affect any other provision of this Agreement and such invalid, illegal
and unenforceable provision shall be reformed and construed so that it will be
valid, legal and enforceable to the maximum extent permitted by law.

         18. COUNTERPARTS. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. The Company shall require
(i) each executive officer who shall, after the date hereof, acquire or receive
the right to acquire any shares of the Company's capital stock, and (ii) each
person who shall, after the date HEREOF, hold, acquire or receive the right to
acquire more than 100,000 shares of the Company's capital stock (appropriately
adjusted for any stock split,

                                      -11-
<PAGE>

recapitalization or other reorganization), as a condition to such acquisition,
to become a party to this Agreement by executing and delivering to the Company
an Instrument of Accession in the form of SCHEDULE II hereto.

         19. SECTION HEADINGS. The headings contained in this Agreement are for
reference purposes only and shall not in any way affect the meaning or
interpretation of this Agreement.

         20. GOVERNING LAW. This Agreement shall be construed and enforced in
accordance with and governed by the General Corporation Law of the State of
Delaware.

         21. AGGREGATION OF STOCK. All securities of the Company held or
acquired by an affiliate of any Investor or entities under common management
with or managed by such Investor shall be aggregated with those held or acquired
by such Investor for the purpose of determining the availability of or discharge
of any rights of such Investor under this Agreement.

                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

                                      -12-
<PAGE>

                               FURNITURE.COM, INC.

               THIRD AMENDED AND RESTATED STOCKHOLDERS' AGREEMENT

                           Counterpart Signature Page

         IN WITNESS WHEREOF, the Company has caused this Agreement to be
executed as of the date first above written.

THE COMPANY:
------------

FURNITURE.COM, INC.,

By: /s/ Alex Seldin
   ---------------------------
Name: Alex Seldin
Title: VP, Legal and Business Affairs

                                     -13-

<PAGE>

                                                                     SCHEDULE I
                                                                     ----------

                                  FURNITURE.COM

                        SCHEDULE OF HOLDERS AND INVESTORS
                        ---------------------------------

<TABLE>
<CAPTION>

NAMES AND ADDRESSES                                NO. OF CLASS B COMMON SHARES
-------------------                                ----------------------------
<S>                                                <C>
FOUNDERS
--------
Steven Rothschild                                                     4,089,400
408 Pleasant Street
Suite 2000
Worcester, MA  01609

Misha Katzc/o Furniture.com, Inc.                                       165,800
1881 Worcester Road,Suite 2
Worcester, MA  01608-2295

TOTAL CLASS B COMMON SHARES:                                          4,255,200
</TABLE>

                                      -14-
<PAGE>

<TABLE>
<S>                                                <C>
NON-FOUNDER STOCKHOLDERS
------------------------
Michael Barach
c/o Bessemer Venture Partners                                            165,800
83 Walnut Street
Wellesley, MA  02181

Andrew Brooks                                                            884,403
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Rose Mauriello                                                           150,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Richard Clark                                                             20,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Lee Chaissan                                                              80,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Charles Anderson                                                         100,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Peter Halunen                                                            100,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Kirsten Von Hassel                                                       150,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

Carl Prindle                                                             150,000
c/o Furniture.com, Inc.
1881 Worcester Road, Suite 2
Framingham, MA 01701

TOTAL CLASS B COMMON SHARES:                                           1,788,774
</TABLE>

                                      -15-
<PAGE>

                                    INVESTORS
                                    ---------

<TABLE>
<CAPTION>

                                    Number of         Number of         Number of          Number of         Number of
                                    Series A           Class A           Series B          Series C           Series D
                                Preferred Shares    Common Shares    Preferred Shares  Preferred Shares   Preferred Shares
                                ----------------    -------------    ----------------  ----------------   ----------------
<S>                                <C>               <C>               <C>                 <C>              <C>
Brand Equity Ventures I, L.P.       1,485,000         1,500,000        1,056,338           67,540                 0
Three Pickwick Plaza
Greenwich, CT  06830
Attn:  Christopher P. Kirchen

Bessemer Venture Investors, L.P.       70,290            71,000          140,845               0                 0
1400 Old Country Road,
Suite 407
Westbury, NY  11590
Attn: Robert Buescher

Bessemer Venture Partners IV L.P.     422,631           426,900          774,648           40,524             63,830
1400 Old Country Road,
Suite 407
Westbury, NY  11590
Attn: Robert Buescher

Bessec Ventures IV L.P.               249,579           252,100          492,958           27,016             42,553
1400 Old Country Road, Suite
407
Westbury, NY 11590

Shad Run Investments, L.P.              0                 0              528,169               0                 0
3512 Clay Street
San Francisco, CA 94118

Comdisco, Inc.                          0                 0              352,113            135,079           106,383
3000 Sand Hill Road
Building 1, Suite 155
Menlo Park, CA 94025

Robert J. Reynolds                      0                 0               88,028               0               10,000
74 Greenwood Way
Mill Valley, CA 94941

Mitchell P. Bartlett                    0                 0               88,028               0               10,000
Diane Rauscher Plaza
60 South 6th Street
Minneapolis, MN 55402-4422
</TABLE>

                                      -16-
<PAGE>

<TABLE>

<S>                                <C>               <C>                <C>                 <C>               <C>
Michael Barach                        395,700           400,000              0                  0                 0
c/o Bessemer Venture Partners
83 Walnut Street
Wellesley, MA  02181

The Trustees of Amherst                66,000            66,666              0                  0                 0
College for the Michael I. &
Holly H. Barach Charitable
Remainder Unitrust
Campus Box 2203
P.O. Box 5000
Amherst, MA  01002-5000

The Trustees of Amherst                33,000            33,334              0                  0                 0
College for the Michael I. &
Holly H. Barach Charitable
Remainder Unitrust II
Campus Box 2203
P.O. Box 5000
Amherst, MA  01002-5000

Don Pettini                             9,900            10,000              0                  0                 0
9 Russett Lane
Andover, MA  01810

Rowland Moriarty                      148,500           150,000              0                  0                 0
Charles River Associates
33rd Floor - 200 Clarendon St.
Boston, MA  02116

Richard J. Resch                       99,000           100,000              0                  0                 0
K.I.
1330 Bellevue Street
Greenbay, WI  54302

@Ventures III, L.P.                     0                 0             2,115,363           324,603           287,599
100 Brickstone Square
Andover, MA 01810
Attn: Marc Poirier

CMG@Ventures III, L.L.C.                0                 0               700,704           107,523            95,266
100 Brickstone Square
Andover, MA 01810
Attn: Andrew J. Hajducky

@Ventures Investors, LLC *              0                 0                70,423            10,807             9,574
100 Brickstone Square
Andover, MA 01810
Attn: Marc Poirier
</TABLE>

                                      -17-
<PAGE>

<TABLE>
<S>                               <C>               <C>            <C>                <C>                <C>
@Ventures Foreign Fund III, L.P. *     0                 0              634,637            97,385           86,284
100 Brickstone Square
Andover, MA 01810
Attn: Marc Poirier

Debra S. Leizman, as                 10,000            10,000               0                  0                 0
Custodian under the Ohio
Transfers to Minors Act for
the benefit of Eve J. Kerman

Debra S. Leizman, as                 10,000            10,000               0                  0                 0
Custodian under the Ohio
Transfers to Minors Act for
the benefit of Hannah M. Kerman

Debra S. Leizman, as                 10,000            10,000               0                  0                 0
Custodian under the Ohio
Transfers to Minors Act for
the benefit of Sophia L. Kerman

Arkaro Holding B.V.                     0                 0                 0              1,350,795       244,949
Locatellikade 1
Parnassustoren
1076 AZ Amsterdam
P.O. Box 75215
1070 AE Amsterdam
The Netherlands
Attn: Maria C. van der Sluijs-
Plantz

Covestco-Ateura, LLC                    0                 0                 0              1,080,635       265,957
c/o Jura Trust
Mitteldorf 1
Vaduz, Liechtenstein, FL-9490
Attn:  Albin A. Johann

With copies to:

Dr. Richard J. Haas Partners
199 Piccadilly
London W1V 9LE
Attn:  Robert Haas and
Michael Russell

Barnard & Co., L.L.C.
590 Madison Avenue, 37th
Floor
New York, NY 10022
Attn:  Joel Koblentz
</TABLE>

                                      -18-
<PAGE>

<TABLE>
<S>                                 <C>               <C>               <C>                <C>               <C>
ATGF II                                 0                 0                 0               726,982              0
c/o Amerindo Investment
Advisors Inc.
399 Park Avenue 2nd Floor
New York, NY  10022
Attn:  Jessica Caruso

RRE Investors, L.P.                     0                 0                 0               261,352            51,383
126 East 56th Street
New York, NY  10022

RRE Investors Fund, L.P.                0                 0                 0               143,886            28,404
P.O. Box 31106 SMB
West Bay Road
Grand Cayman, Cayman
Islands B.W.I.

Matthew Fitzmaurice                     0                 0                 0                80,000              0
1771 James Avenue South
Minneapolis, MN  55403

James Stableford                        0                 0                 0                 3,500              0
Amerindo Investment
Advisors Inc.
43 Upper Grosvenor Street
London W1x 9PG
England

Rachel Hyman                            0                 0                 0                6,754               0
325 W. 22nd Street, Apt. 3
New York, NY  10011

Trellus Partners, LP                    0                 0                 0               263,405            36,450
152 W. 57th Street, 57th
Floor
New York, NY  10011

Munder NetNet Fund                      0                 0                 0                  0            1,595,744
480 Pierce Street, Ste 300
Birmingham, MI  48009

Litton Master Trust                     0                 0                 0                  0              106,383
c/o Amerindo Investment
Advisors Inc.
399 Park Avenue, 22nd Floor
New York, NY  10022

TOTAL                               3,009,600         3,040,000         7,042,254          4,727,786        3,040,759
                                    =========         =========         =========          =========        =========
</TABLE>

                                      -19-
<PAGE>

                                                                    SCHEDULE II
                                                                    -----------

                                  FURNITURE.COM

                             INSTRUMENT OF ACCESSION
                             -----------------------

         The undersigned, _________________, as a condition precedent to
becoming the owner or holder of record of ___________________ (______) shares of
the [Class A Common Stock or Class B Common Stock], par value $.01 per share, of
Furniture.com, a Delaware corporation (the "Company"), hereby agrees to become a
Holder party to and bound by that certain Third Amended and Restated
Stockholders' Agreement, dated as of December 30, 1999 by and among the Company
and other stockholders of the Company. This Instrument of Accession shall take
effect and shall become an integral part of the said Third Amended and Restated
Stockholders' Agreement immediately upon execution and delivery to the Company
of this Instrument.

         IN WITNESS WHEREOF, this INSTRUMENT OF ACCESSION has been duly executed
by or on behalf of the undersigned, as a sealed instrument under the laws of the
State of Delaware, as of the date below written.

                               Signature:
                                         ---------------------------------
                               (Print Name)

                                Address:
                                         ---------------------------------

                                Date:
                                     -------------------------------------

                                Accepted:
                                         ---------------------------------

                                FURNITURE.COM

                                By:
                                   ---------------------------------------
                                Name:
                                     -------------------------------------
                                Title:
                                      ------------------------------------
                                Date:
                                    --------------------------------------

                                      -20-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]